<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Second‐generation antidepressants for treatment of seasonal affective disorder - Nussbaumer-Streit, B - 2021 | Cochrane Library</title> <meta content="Second‐generation antidepressants for treatment of seasonal affective disorder - Nussbaumer-Streit, B - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008591.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Second‐generation antidepressants for treatment of seasonal affective disorder - Nussbaumer-Streit, B - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008591.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD008591.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Second‐generation antidepressants for treatment of seasonal affective disorder" name="citation_title"/> <meta content="Barbara Nussbaumer-Streit" name="citation_author"/> <meta content="Danube University Krems" name="citation_author_institution"/> <meta content="Barbara.nussbaumer-streit@donau-uni.ac.at" name="citation_author_email"/> <meta content="Kylie Thaler" name="citation_author"/> <meta content="Danube University Krems" name="citation_author_institution"/> <meta content="Andrea Chapman" name="citation_author"/> <meta content="Danube University Krems" name="citation_author_institution"/> <meta content="Thomas Probst" name="citation_author"/> <meta content="Danube University Krems" name="citation_author_institution"/> <meta content="Dietmar Winkler" name="citation_author"/> <meta content="Medical University of Vienna" name="citation_author_institution"/> <meta content="Andreas Sönnichsen" name="citation_author"/> <meta content="Medical University of Vienna" name="citation_author_institution"/> <meta content="Bradley N Gaynes" name="citation_author"/> <meta content="Gerald Gartlehner" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD008591.pub3" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/03/04" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008591.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008591.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008591.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antidepressive Agents, Second-Generation [adverse effects, *therapeutic use]; Bias; Citalopram [adverse effects, therapeutic use]; Duloxetine Hydrochloride [adverse effects, therapeutic use]; Fluoxetine [adverse effects, therapeutic use]; Morpholines [adverse effects, therapeutic use]; Observational Studies as Topic; Phototherapy; Placebos [therapeutic use]; Quality of Life; Randomized Controlled Trials as Topic; Reboxetine [therapeutic use]; Seasonal Affective Disorder [*drug therapy, therapy]; Thiophenes [adverse effects, therapeutic use]; Treatment Outcome" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008591.pub3&amp;doi=10.1002/14651858.CD008591.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="18M35a5z";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD008591\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD008591\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","zh_HANT","ru","ko","ms","ja","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD008591.pub3",title:"Second\\u2010generation antidepressants for treatment of seasonal affective disorder",firstPublishedDate:"Mar 4, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Common Mental Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008591.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008591.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD008591.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD008591.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008591.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD008591.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD008591.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD008591.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD008591.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD008591.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5558 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD008591.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-sec-0087"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-sec-0043"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-sec-0081"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/appendices#CD008591-sec-0092"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/supinfo/CD008591StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/supinfo/CD008591StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Second‐generation antidepressants for treatment of seasonal affective disorder</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/information#CD008591-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Barbara Nussbaumer-Streit</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/information#CD008591-cr-0005">Kylie Thaler</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/information#CD008591-cr-0006">Andrea Chapman</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/information#CD008591-cr-0007">Thomas Probst</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/information#CD008591-cr-0008">Dietmar Winkler</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/information#CD008591-cr-0009">Andreas Sönnichsen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/information#CD008591-cr-0010">Bradley N Gaynes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008591.pub3/information#CD008591-cr-0011">Gerald Gartlehner</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/information/en#CD008591-sec-0101">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 04 March 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD008591.pub3">https://doi.org/10.1002/14651858.CD008591.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD008591-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008591-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008591-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008591-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008591-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD008591-abs-0008">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD008591-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD008591-abs-0001" lang="en"> <section id="CD008591-sec-0001"> <h3 class="title" id="CD008591-sec-0001">Background</h3> <p>Seasonal affective disorder (SAD) is a seasonal pattern of recurrent depressive episodes that is often treated with second‐generation antidepressants (SGAs), light therapy, or psychotherapy. </p> </section> <section id="CD008591-sec-0002"> <h3 class="title" id="CD008591-sec-0002">Objectives</h3> <p>To assess the efficacy and safety of second‐generation antidepressants (SGAs) for the treatment of seasonal affective disorder (SAD) in adults in comparison with placebo, light therapy, other SGAs, or psychotherapy. </p> </section> <section id="CD008591-sec-0003"> <h3 class="title" id="CD008591-sec-0003">Search methods</h3> <p>This is an update of an earlier review first published in 2011. We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2020, Issue 1) in the Cochrane Library (all years), Ovid MEDLINE, Embase, and PsycINFO (2011 to January 2020), together with the Cochrane Common Mental Disorders Controlled Trials Register (CCMDCTR) (all available years), for reports of randomised controlled trials (RCTs). We hand searched the reference lists of all included studies and other systematic reviews. We searched ClinicalTrials.gov for unpublished/ongoing trials. We ran a separate update search for reports of adverse events in the Ovid databases.  </p> </section> <section id="CD008591-sec-0004"> <h3 class="title" id="CD008591-sec-0004">Selection criteria</h3> <p>For efficacy we included RCTs of SGAs compared with other SGAs, placebo, light therapy, or psychotherapy in adult participants with SAD. For adverse events we also included non‐randomised studies. </p> </section> <section id="CD008591-sec-0005"> <h3 class="title" id="CD008591-sec-0005">Data collection and analysis</h3> <p>Two review authors independently screened abstracts and full‐text publications against the inclusion criteria. Data extraction and 'Risk of bias' assessment were conducted individually. We pooled data for meta‐analysis where the participant groups were similar, and the studies assessed the same treatments with the same comparator and had similar definitions of outcome measures over a similar duration of treatment. </p> </section> <section id="CD008591-sec-0006"> <h3 class="title" id="CD008591-sec-0006">Main results</h3> <p>In this update we identified no new RCT on the effectiveness of SGAs in SAD patients. We included 2 additional single‐arm observational studies that reported on adverse events of SGAs.  </p> <p>For efficacy we included three RCTs of between five and eight weeks' duration with a total of 204 participants. For adverse events we included two RCTs and five observational (non‐randomised) studies of five to eight weeks' duration with a total of 249 participants. All participants met the DSM (<i>Diagnostic and Statistical Manual of Mental Disorders</i>) criteria for SAD. The average age ranged from 34 to 42 years, and the majority of participants were female (66% to 100%). </p> <p>Results from one trial with 68 participants showed that fluoxetine (20/36) was numerically superior to placebo (11/32) in achieving clinical response; however, the confidence interval (CI) included both a potential benefit as well as no benefit of fluoxetine (risk ratio (RR) 1.62, 95% CI 0.92 to 2.83, very low‐certainty evidence). The number of adverse events was similar in both groups (very low‐certainty evidence). </p> <p>Two trials involving a total of 136 participants compared fluoxetine versus light therapy. Meta‐analysis showed fluoxetine and light therapy to be approximately equal in treating seasonal depression: RR of response 0.98 (95% CI 0.77 to 1.24, low‐certainty evidence), RR of remission 0.81 (95% CI 0.39 to 1.71, very low‐certainty evidence). The number of adverse events was similar in both groups (low‐certainty evidence). </p> <p>We did not identify any eligible study comparing SGA with another SGA or with psychotherapy.</p> <p>Two RCTs and five non‐randomised studies reported adverse event data on a total of 249 participants who received bupropion, fluoxetine, escitalopram, duloxetine, nefazodone, reboxetine, light therapy, or placebo. We were only able to obtain crude rates of adverse events, therefore caution is advised regarding interpretation of this information. Between 0% and 100% of participants who received an SGA suffered an adverse event, and between 0% and 25% of participants withdrew from the study due to adverse events. </p> </section> <section id="CD008591-sec-0007"> <h3 class="title" id="CD008591-sec-0007">Authors' conclusions</h3> <p>Evidence for the effectiveness of SGAs is limited to one small trial of fluoxetine compared with placebo showing a non‐significant effect in favour of fluoxetine, and two small trials comparing fluoxetine against light therapy suggesting equivalence between the two interventions. The lack of available evidence precluded us from drawing any overall conclusions on the use of SGAs for SAD. Further, larger RCTs are required to expand and strengthen the evidence base on this topic, and should also include comparisons with psychotherapy and other SGAs. </p> <p>Data on adverse events were sparse, and a comparative analysis was not possible. The data we obtained on adverse events is therefore not robust, and our confidence in the data is limited. Overall, up to 25% of participants treated with SGAs for SAD withdrew from the study early due to adverse events. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD008591-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008591-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD008591-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD008591-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008591-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008591-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD008591-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD008591-abs-0009">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD008591-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD008591-abs-0016">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD008591-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD008591-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD008591-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD008591-abs-0002" lang="en"> <h3>Second‐generation antidepressants for winter depression</h3> <p><b>Background</b> </p> <p>Seasonal affective disorder (winter depression) is a type of depression that recurs in the autumn and lasts until the spring. Its symptoms are similar to those of regular depression, except sufferers are usually very tired and have an increase in their appetite. It is more common in countries with few daylight hours in winter. One of the mainstays of treatment for all depression, including winter depression, is second‐generation antidepressants (SGAs), such as selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs). It is not clear how well these drugs work and how they compare to each other or to other types of therapy for winter depression, such as light therapy. </p> <p><b>Results</b> </p> <p>We found three trials with a total of 204 participants that looked at one SGA (fluoxetine) compared with placebo (dummy pill) or light therapy. One trial (68 participants) compared fluoxetine with placebo, although participants receiving fluoxetine were more likely to respond to treatment, there wasn't enough data to be sure of any differences with placebo. Approximately the same number of participants in both groups experienced a side effect. </p> <p>We found two trials with a total of 136 participants that compared fluoxetine with light therapy. When we combined the results of these two trials, we found that the two treatments were similar in their effects: approximately 66 out of 100 people improved in both the fluoxetine and light therapy groups. The number of participants with side effects was also about the same in the fluoxetine and light therapy groups. </p> <p>We found five additional studies that provided information on the safety of SGAs for the treatment of winter depression. They reported side effects of the SGAs bupropion, fluoxetine, escitalopram, duloxetine, nefazodone, and reboxetine. We were unable to compare the drugs directly, but we can report that about 0% to 25% of people left the study early due to side effects, and the most common side effects were nausea, diarrhoea, disturbed sleep, decreased sex drive, dry mouth, and agitation. We could not compare the rates of side effects in people taking SGAs compared with placebo, which means that our confidence in the information on side effects is limited. </p> <p><b>Certainty of the evidence</b> </p> <p>The certainty of evidence for the effectiveness and safety of fluoxetine compared to placebo was very low. The certainty of evidence for the effectiveness and safety of fluoxetine compared to light therapy was low. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD008591-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD008591-sec-0087"></div> <h3 class="title" id="CD008591-sec-0088">Implications for practice</h3> <section id="CD008591-sec-0088"> <p>Based on the results of the one available randomised controlled trial (RCT) for our first comparison, it is unclear whether fluoxetine is more efficacious than placebo for seasonal affective disorder (SAD). Clinicians should be aware that no RCT evidence supports the use of fluoxetine for SAD, and that further research is needed to establish the effects of fluoxetine for this disorder. </p> <p>Similarly, the pooled results from two RCTs of fluoxetine versus light therapy did not demonstrate superiority of either therapy. Our findings show little difference in efficacy and safety between fluoxetine and light therapy. However, the currently available evidence is based on two small studies, which limits confidence in the findings<i>.</i> </p> <p>In making treatment decisions, clinicians can discuss with patients what is known and not known about the risks and benefits of SGAs in treating SAD. Part of this discussion might include the information that SAD is seen as a subtype of MDD, where there is evidence of SGA efficacy (<a href="./references#CD008591-bbs2-0025" title="Gartlehner G,  Wagner G,  Matyas N, TitscherV , GreimelJ , LuxL , et al. Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews. BMJ Open2017;7:e014912. [DOI: 10.1136/bmjopen-2016-014912]">Gartlehner 2017</a>). </p> </section> <h3 class="title" id="CD008591-sec-0089">Implications for research</h3> <section id="CD008591-sec-0089"> <p>The current evidence base for the use of SGAs to treat SAD is very sparse. To demonstrate the efficacy and safety of fluoxetine and other SGAs compared with placebo, future trials should be sufficiently powered to detect true differences. Randomisation, allocation concealment, and attrition should be optimised and better reported. Well‐conducted, adequately powered, randomised, placebo‐controlled trials of other SGAs are also needed to demonstrate their efficacy for treating SAD, as none are currently available. </p> <p>No randomised trial evidence supports the use of any SGA for SAD. Once the general efficacy of an SGA for SAD has been established, comparative (head‐to‐head) trials of the SGAs are needed to characterise the comparative efficacy between the SGAs and the comparison between SGAs and light therapy. Additional, much larger trials comparing fluoxetine and light therapy are required to clarify whether any clinically important differences exist between these two therapeutic approaches. New trials comparing SGAs and psychotherapy for SAD are also needed. </p> <p>All future trials of SGAs for SAD should adequately and comprehensively capture the number and types of adverse events, ideally using a prespecified side‐effect rating scale. The allocation concealment in the trials included in this review was well‐conducted and could serve as a model for future researchers. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD008591-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD008591-sec-0008"></div> <div class="table" id="CD008591-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Fluoxetine compared with placebo for seasonal affective disorder</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Fluoxetine compared with placebo for seasonal affective disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with seasonal affective disorder </p> <p><b>Settings:</b> outpatients </p> <p><b>Intervention:</b> fluoxetine </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fluoxetine</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Response (&gt; 50% improvement on 29‐item HAM‐D SIGH‐SAD)</b> </p> <p>5 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 100</b> </p> <p> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>56 per 100</b><br/>(32 to 97) </p> <p> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.62</b> (0.92 to 2.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68<br/>(1 study, <a href="./references#CD008591-bbs2-0002" title="LamR , GormanC , MichalonM , SteinerM , LevittA , CorralM , et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. American Journal of Psychiatry1995;152(12):1765-70. ">Lam 1995</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical Global Impression – Improvement score</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence identified.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence identified.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Remission</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence identified.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Speed of onset of response</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence identified.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall adverse events</b> </p> <p>5 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>91 per 100</b> </p> <p> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>97 per 100</b><br/>(86 to 110) </p> <p> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.07</b> (0.95 to 1.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68<br/>(1 study, <a href="./references#CD008591-bbs2-0002" title="LamR , GormanC , MichalonM , SteinerM , LevittA , CorralM , et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. American Journal of Psychiatry1995;152(12):1765-70. ">Lam 1995</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is the rate in the placebo group. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the fluoxetine group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>HAM‐D SIGH‐SAD</b> : Structured Interview Guide for the Hamilton Depression Rating Scale ‐ Seasonal Affective Disorder Version; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect </p> <p><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different </p> <p><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect </p> <p><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by one level because the trial has an unclear risk of bias in all but one 'Risk of bias' domains, and two levels for serious imprecision due to the small number of participants in the trial and because the confidence interval includes both benefit and no effect. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD008591-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Fluoxetine compared with light therapy for seasonal affective disorder</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Fluoxetine compared with light therapy for seasonal affective disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with seasonal affective disorder </p> <p><b>Settings:</b> outpatients </p> <p><b>Intervention:</b> fluoxetine </p> <p><b>Comparison:</b> light therapy </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Light therapy</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fluoxetine</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Response (&gt; 50% improvement on 24‐item HAM‐D SIGH‐SAD)</b> </p> <p>5 to 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>67 per 100</b><br/>(52 to 87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.98</b> (0.77 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>136<br/>(2 studies, <a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>, </p> <p><a href="./references#CD008591-bbs2-0007" title="RuhrmannS , KasperS , HawellekB , MartinezB , HöflichG , NickelsonT , et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychological Medicine1998;28:923-33. RuhrmannS , KasperS , HawellekB , MartinezB , HoflichG , NickelsenT , et al. Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder (SAD) [abstract]. Pharmacopsychiatry [abstracts from the 18th Symposium of AGNP, Nuremberg 1993]1993;26:193. RuhrmannS , KasperS , HawellekB , PetersS , RaoML , HoflichG , et al. Selective serotonin re-uptake inhibitors for treatment of seasonal affective disorder (SAD) [poster abstract]. Clinical Neuropharmacology1992;15(Suppl 1, Pt B):341. ">Ruhrmann 1998</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical Global Impression – Improvement score</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No evidence identified.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life (SF‐20 and Q‐LES‐Q)</b> </p> <p>8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SF‐20: The mean change from baseline was 7.82</p> <p>Q‐LES‐Q:The mean change from baseline was 20.26</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SF‐20: The mean change from baseline was 1.56 higher (4.2 lower to 7.32 higher)</p> <p>Q‐LES‐Q:The mean change from baseline was 1.21 higher (4.87 lower to 7.29 higher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96</p> <p>(1 study, <a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean difference of change from baseline self calculated by review authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Remission (response plus end score 8 or less)</b> </p> <p>5 to 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>55 per 100</b><br/>(22 to 94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.81</b> (0.39 to 1.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>136<br/>(2 studies, <a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>, </p> <p><a href="./references#CD008591-bbs2-0007" title="RuhrmannS , KasperS , HawellekB , MartinezB , HöflichG , NickelsonT , et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychological Medicine1998;28:923-33. RuhrmannS , KasperS , HawellekB , MartinezB , HoflichG , NickelsenT , et al. Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder (SAD) [abstract]. Pharmacopsychiatry [abstracts from the 18th Symposium of AGNP, Nuremberg 1993]1993;26:193. RuhrmannS , KasperS , HawellekB , PetersS , RaoML , HoflichG , et al. Selective serotonin re-uptake inhibitors for treatment of seasonal affective disorder (SAD) [poster abstract]. Clinical Neuropharmacology1992;15(Suppl 1, Pt B):341. ">Ruhrmann 1998</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to onset of response</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No evidence identified</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events (at least 1 treatment‐emergent adverse event)</b> </p> <p>8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>75 per 100</b><br/>(60 to 94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.97</b> (0.78 to 1.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96</p> <p>(1 study, <a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low<sup>4</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is the response rate in the light therapy groups in the 2 included trials. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the fluoxetine group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>HAM‐D SIGH‐SAD</b> : Structured Interview Guide for the Hamilton Depression Rating Scale ‐ Seasonal Affective Disorder Version; <b>NR:</b> not reported; <b>Q‐LES‐Q:</b> Quality of Life Enjoyment and Satisfaction Questionnaire; <b>RR:</b> risk ratio; <b>SF‐20:</b> 20‐Item Short Form Health Survey </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect </p> <p><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different </p> <p><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect </p> <p><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by one level because the risk of bias was high in one study, and one level for imprecision because the optimal information size was not reached (too few participants).<br/><sup>2</sup>The data are from only one trial with a low risk of bias; however, we downgraded by two level for imprecision because the optimal information size was not reached (too few participants) and the confidence interval was broad including both a benefit for fluoxetin and for light therapy.<br/><sup>3</sup>Downgraded by one level for inconsistency, one level because the risk of bias was high in one study, and one level for imprecision because the optimal information size was not reached (too few participants).<br/><sup>4</sup>The data are from only one trial with a low risk of bias; however, we downgraded by one level for imprecision because the optimal information size was not reached (too few participants), and one level for indirectness because the outcome encompasses many adverse effects, allowing no direct conclusions. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD008591-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD008591-sec-0009"></div> <section id="CD008591-sec-0010"> <h3 class="title" id="CD008591-sec-0010">Description of the condition</h3> <p>Seasonal affective disorder (SAD) is a seasonal pattern of recurrent major depressive episodes that occur during autumn or winter and remit in spring or summer (<a href="./references#CD008591-bbs2-0052" title="RosenthalNE , SackDA , GillinJC , LewyAJ , GoodwinFK , DavenportY , et al. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Archives of General Psychiatry1984;41(1):72-80.">Rosenthal 1984</a>). In addition to the predictable seasonal pattern of depression, people suffering from SAD experience atypical symptoms including hypersomnia, carbohydrate craving with increased appetite and weight gain, and extreme fatigue (<a href="./references#CD008591-bbs2-0053" title="SohnCH , LamRW . Update on the biology of seasonal affective disorder. CNS Spectrums2005;10(8):635-46.">Sohn 2005</a>). The prevalence of SAD ranges from 1.5% to 10%, with higher prevalence rates in more northern latitudes (<a href="./references#CD008591-bbs2-0017" title="ByrneB , BrainardGC . Seasonal affective disorder and light therapy. Sleep Medicine Clinics2008;3(2):307-15.">Byrne 2008</a>; <a href="./references#CD008591-bbs2-0039" title="LevittAJ , BoyleMH , JoffeRT , BaumalZ . Estimated prevalence of the seasonal subtype of major depression in a Canadian community sample. Canadian Journal of Psychiatry/Revue Canadienne de Psychiatrie2000;45(7):650-4.">Levitt 2000</a>; <a href="./references#CD008591-bbs2-0057" title="Wirz-JusticeA , AjdacicV , RösslerW , SteinhausenHC , AngstJ . Prevalence of seasonal depression in a prospective cohort study. European Archives of Psychiatry and Clinical Neuroscience2018;269(7):833-9. [DOI: 10.1007/s00406-018-0921-3]">Wirz‐Justice 2018</a>). </p> <p>SAD is a multifactorial condition. Chronobiological mechanisms related to circadian rhythms, melatonin, alterations of the serotonergic neurotransmitter system, and photoperiodism (length of dark hours relative to light hours in a 24‐hour period) are all thought to play a role in SAD (<a href="./references#CD008591-bbs2-0018" title="CiarleglioCM , ResuehrHES , McMahonDG . Interactions of the serotonin and circadian systems: nature and nurture in rhythms and blues. Neuroscience2011;197:8-16. [DOI: 10.1016/j.neuroscience.2011.09.036]">Ciarleglio 2011</a>; <a href="./references#CD008591-bbs2-0038" title="LevitanRD . The chronobiology and neurobiology of winter seasonal affective disorder. Dialogues in Clinical Neuroscience2007;9(3):315-24.">Levitan 2007</a>; <a href="./references#CD008591-bbs2-0048" title="OldhamMA , CirauloDA . Bright light therapy for depression: a review of its effects on chronobiology and the autonomic nervous system. Chronobiology International2014;31(3):305-19.">Oldham 2014</a>). Although it is commonly believed that a seasonal pattern of depression occurs almost exclusively in locations with very few hours of daylight in winter (<a href="./references#CD008591-bbs2-0012" title="BlashkoC . A double-blind, placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder. In: 8th ECNP (European College of Neuropsychopharmacology) Congress; 1995 09 30 - 10 04; Venice, Italy. Venice, Italy: European College of Neuropsychopharmacology, 1995. BlashkoC . Drug treatment of winter depression: How effective is it, and what can it tell us about the biology of SAD? In: Sixth World Congress of Biological Psychiatry; 1997 06 22-27, Nice, France. Nice, France: World Federation of the Societies of Biological Psychiatry, 1997. MoscovitchA , BlashkoC , EaglesJ , DarcoutG , ThompsonC , KasperS , et al. A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder. Psychopharmacology2004;171(4):390-7. ">Moscovitch 2004</a>), a Canadian study on the prevalence of SAD over eight degrees of latitude did not support this theory (<a href="./references#CD008591-bbs2-0040" title="LevittAJ , BoyleMH . The impact of latitude on the prevalence of seasonal depression. Canadian Journal of Psychiatry/Revue Canadienne de Psychiatrie2002;47(4):361-7.">Levitt 2002</a>). It is assumed that the major monoaminergic neurotransmitters serotonin, norepinephrine, and dopamine are fundamental to the pathology of SAD, and that the condition results from the interaction of genetic vulnerability and environmental factors (<a href="./references#CD008591-bbs2-0027" title="GondaX , EszláriN , SutoriS , AspanN , RihmerZ , JuhaszG , et al. Nature and nurture: effects of affective temperaments on depressive symptoms are markedly modified by stress exposure. Front Psychiatry2020;30(11):599. [DOI: 10.3389/fpsyt.2020.00599]">Gonda 2020</a>; <a href="./references#CD008591-bbs2-0038" title="LevitanRD . The chronobiology and neurobiology of winter seasonal affective disorder. Dialogues in Clinical Neuroscience2007;9(3):315-24.">Levitan 2007</a>). </p> </section> <section id="CD008591-sec-0011"> <h3 class="title" id="CD008591-sec-0011">Description of the intervention</h3> <p>Since their introduction to the market in the late 1980s, second‐generation antidepressants (SGAs) have established themselves as a dominant form of pharmacotherapy for depressive disorders (<a href="./references#CD008591-bbs2-0024" title="GartlehnerG , HansenRA , MorganL , ThalerK , LuxL , Van NoordM , et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Annals of Internal Medicine2011;155(11):772-85.">Gartlehner 2011</a>, <a href="./references#CD008591-bbs2-0025" title="Gartlehner G,  Wagner G,  Matyas N, TitscherV , GreimelJ , LuxL , et al. Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews. BMJ Open2017;7:e014912. [DOI: 10.1136/bmjopen-2016-014912]">Gartlehner 2017</a>). </p> <p>In general, SGAs work through their effect on neurotransmitters in the central nervous system. SGAs can be classified into three groups: selective serotonin reuptake inhibitors (SSRIs); serotonin and norepinephrine reuptake inhibitors (SNRIs); and others. The SSRIs (citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline) act by selectively inhibiting the reuptake of serotonin (5‐hydroxy‐tryptamine, 5‐HT) at the presynaptic neuronal membrane. The SNRIs (desvenlafaxine, duloxetine, levomilnacipran, milnacipran, and venlafaxine) are potent inhibitors of serotonin and norepinephrine reuptake. Some SSRIs and SNRIs may also exert dopamine reuptake inhibition, but this is not essential to their categorisation. Other SGAs include mirtazapine, which is an antagonist at presynaptic alpha‐2 autoreceptors (which disinhibits norepinephrine release) and a 5‐HT2 receptor antagonist (<a href="./references#CD008591-bbs2-0023" title="GartlehnerG , MorganLC , ThiedaP , ThalerK , HansenRA , GaynesB , et al. Drug class review: Second generation antidepressants [Drug Effectiveness Review Project (DERP) report]. Oregon, USA: Oregon Health &amp; Science University, October 2008.">Gartlehner 2008</a>; <a href="./references#CD008591-bbs2-0031" title="HansenRA , MooreCG , DusetzinaSB , LeinwandBI , GartlehnerG , GaynesB . Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose. Medical Decision Making2009;29(1):91-103.">Hansen 2009</a>). Bupropion is an inhibitor of the neuronal uptake of norepinephrine and dopamine (<a href="./references#CD008591-bbs2-0037" title="KhanSR , BerendtRT , EllisonCD , CiavarellaAB , Asafu-AdjayeE , KhanMA , et al. Bupropion hydrochloride. Profiles of Drug Substances, Excipients and Related Methodology2016;41:1-30. [DOI: 10.1016/bs.podrm.2015.12.001]">Khan 2016</a>). Reboxetine is a norepinephrine reuptake inhibitor that does not act on serotonin (<a href="./references#CD008591-bbs2-0036" title="KentJM . SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet2000;355(9207):911-8.">Kent 2000</a>). Similarly, agomelatine is a melatonin‐1 (MT1) and MT2 receptor agonist and 5‐HT2C receptor antagonist (<a href="./references#CD008591-bbs2-0032" title="HickieIB , RogersNL . Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet2011;378(9791):621-31.">Hickie 2011</a>). Vortioxetine is a 5‐HT transporter inhibitor, an agonist at the 5‐HT1A receptor, a partial agonist at the 5‐HT1B receptor and an antagonist at the 5‐HT1D, 5‐HT3 and 5‐HT7 receptor. Vilazodon acts as an SSRI together with agonism at the 5‐HT1A receptor (<a href="./references#CD008591-bbs2-0054" title="WagnerG , SchultesMT , TitscherV , TeuferB , KleringsI , GartlehnerG . Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: a systematic review and network meta-analysis. Journal of Affective Disorders2018;228(1):1-12.">Wagner 2018</a>). </p> <p>Clinical guidelines recommend SGAs for the treatment of SAD (<a href="./references#CD008591-bbs2-0022" title="DGPPN, BÄK, KBV, AWMF, AKDÄ, BPTK, et al. S3-Leitlinie/Nationale Versorgungs-Leitlinie Unipolare Depression - Langfassung [S3-Guideline/National Guideline on unipolar depression - long version]. DGPPN BÄK KBV AWMF AdkÄ BPtK BApK DAGSHG DEGAM DGPM DGPs DGRW für die Leitliniengruppe Unipolare Depression, 2015.">DGPPN 2015</a>; <a href="./references#CD008591-bbs2-0045" title="National Institute for Health and Care Excellence (NICE). Depression in adults: recognition and managment, Clinical guideline [CG90]. www.nice.org.uk/guidance/cg90/chapter/1-Guidance#care-of-all-people-with-depression (accessed prior to 4 February 2021).">NICE 2009</a>). The German depression guideline and the Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders recommend early‐morning bright‐light therapy for SAD (<a href="./references#CD008591-bbs2-0022" title="DGPPN, BÄK, KBV, AWMF, AKDÄ, BPTK, et al. S3-Leitlinie/Nationale Versorgungs-Leitlinie Unipolare Depression - Langfassung [S3-Guideline/National Guideline on unipolar depression - long version]. DGPPN BÄK KBV AWMF AdkÄ BPtK BApK DAGSHG DEGAM DGPM DGPs DGRW für die Leitliniengruppe Unipolare Depression, 2015.">DGPPN 2015</a>, <a href="./references#CD008591-bbs2-0041" title="MalhiGS , BellE ,  BassettD , BoyceP , BryantR , Hazell P et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Australian &amp; New Zealand Journal of Psychiatry2021;55(1):7-117.">Malhi 2021</a>), whilst the National Institute for Health and Care Excellence (NICE) also recommends psychotherapy for the condition (<a href="./references#CD008591-bbs2-0045" title="National Institute for Health and Care Excellence (NICE). Depression in adults: recognition and managment, Clinical guideline [CG90]. www.nice.org.uk/guidance/cg90/chapter/1-Guidance#care-of-all-people-with-depression (accessed prior to 4 February 2021).">NICE 2009</a>). We therefore investigated the efficacy and adverse events of SGAs when used for the treatment of SAD and included other treatment alternatives like light therapy and psychotherapy as comparators. </p> </section> <section id="CD008591-sec-0012"> <h3 class="title" id="CD008591-sec-0012">How the intervention might work</h3> <p>Much research into the aetiology of SAD has focused on the role of circadian rhythms and melatonin (<a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>), and early‐morning bright‐light exposure is a common and effective treatment for SAD (<a href="./references#CD008591-bbs2-0026" title="GoldenRN , GaynesBN , EkstromRD , HamerRM , JacobsenFM , SuppesT , et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. American Journal of Psychiatry2005;162(4):656-62.">Golden 2005</a>; <a href="./references#CD008591-bbs2-0050" title="PjrekE , FriedrichME , CambioliL , DoldM , JägerF , KomorowskiA , et al. The efficacy of light therapy in the treatment of seasonal affective disorder: a meta-analysis of randomized controlled trials. Psychotherapy and Psychosomatics2020;89(1):17-24. [DOI: 10.1159/000502891]">Pjrek 2020</a>). On the neurochemical level, changes in both the serotonergic and catecholaminergic neurotransmitter systems seem to play a key role in the disorder (<a href="./references#CD008591-bbs2-0044" title="NeumeisterA , KonstantinidisA , Praschak-RiederN , WilleitM , HilgerE , StastnyJ , et al. Monoaminergic function in the pathogenesis of seasonal affective disorder. International Journal of Neuropsychopharmacology2001;4:409-20. [DOI: 10.1017/S1461145701002644]">Neumeister 2001</a>). Targeting these systems with serotonin or norepinephrine reuptake inhibition, or both, provides the biological plausibility for the mechanism of action of the SGAs. Indeed, the therapeutic action of SGAs in SAD is similar to that in non‐seasonal depression, even though the role of daylight and circadian rhythms in the pathogenesis of SAD might be different to non‐seasonal depression (<a href="./references#CD008591-bbs2-0018" title="CiarleglioCM , ResuehrHES , McMahonDG . Interactions of the serotonin and circadian systems: nature and nurture in rhythms and blues. Neuroscience2011;197:8-16. [DOI: 10.1016/j.neuroscience.2011.09.036]">Ciarleglio 2011</a>; <a href="./references#CD008591-bbs2-0049" title="PjrekE , KonstantinidisA , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis. Journal of Psychiatric Research2009;43(8):792-7.">Pjrek 2005</a>). </p> </section> <section id="CD008591-sec-0013"> <h3 class="title" id="CD008591-sec-0013">Why it is important to do this review</h3> <p>Bright‐light therapy is considered to be an effective treatment for seasonal affective disorder (<a href="./references#CD008591-bbs2-0050" title="PjrekE , FriedrichME , CambioliL , DoldM , JägerF , KomorowskiA , et al. The efficacy of light therapy in the treatment of seasonal affective disorder: a meta-analysis of randomized controlled trials. Psychotherapy and Psychosomatics2020;89(1):17-24. [DOI: 10.1159/000502891]">Pjrek 2020</a>), and is recommended in clinical guidelines (<a href="./references#CD008591-bbs2-0022" title="DGPPN, BÄK, KBV, AWMF, AKDÄ, BPTK, et al. S3-Leitlinie/Nationale Versorgungs-Leitlinie Unipolare Depression - Langfassung [S3-Guideline/National Guideline on unipolar depression - long version]. DGPPN BÄK KBV AWMF AdkÄ BPtK BApK DAGSHG DEGAM DGPM DGPs DGRW für die Leitliniengruppe Unipolare Depression, 2015.">DGPPN 2015</a>; <a href="./references#CD008591-bbs2-0035" title="KennedySH , LamRW , CohenNL , RavindranAV , CANMAT Depression Work Group. Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Canadian Journal of Psychiatry/Revue Canadienne de Psychiatrie2001;46(Suppl 1):38S-58S.">Kennedy 2001</a>). Indeed, one systematic review and meta‐analysis suggested that effect sizes for light therapy in SAD are comparable to those seen in trials of SGAs (<a href="./references#CD008591-bbs2-0026" title="GoldenRN , GaynesBN , EkstromRD , HamerRM , JacobsenFM , SuppesT , et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. American Journal of Psychiatry2005;162(4):656-62.">Golden 2005</a>). Also, the last version of this review found similar effects of light therapy and SGAs in SAD treatment (<a href="./references#CD008591-bbs2-0059" title="ThalerK , DelivukM , ChapmanA , GaynesBN , KaminskiA , GartlehnerG . Second-generation antidepressants for seasonal affective disorder. Cochrane Database of Systematic Reviews2011, Issue 12. Art. No: CD008591. [DOI: 10.1002/14651858.CD008591.pub2]">Thaler 2011</a>). Unfortunately, light therapy is time intensive; typical regimens suggest at least 30 minutes of light exposure immediately after waking (<a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>), which may result in poor adherence to therapy (<a href="./references#CD008591-bbs2-0042" title="MichalakEE , HayesS , WilkinsonC , HoodK , DowrickC . Treatment compliance in light therapy: do patients do as they say they do?Journal of Affective Disorders2002;68(2-3):341-2.">Michalak 2002</a>; <a href="./references#CD008591-bbs2-0046" title="Nussbaumer-StreitB , PjrekE , KienC , GartlehnerG , BartovaL , FriedrichME , et al. Implementing prevention of seasonal affective disorder from patients’ and physicians’ perspectives - a qualitative study. BMC Psychiatry2018;18(1):1-10.">Nussbaumer‐Streit 2018</a>). Hence, it was important to determine the efficacy of SGAs in treating SAD, in particular in comparison to light therapy. Furthermore, interest in the comparative efficacy of SGAs is still high, with many reviews seeking to provide guidance to physicians about the most appropriate SGA for depression (<a href="./references#CD008591-bbs2-0019" title="CiprianiA , Furukawa TA, SalantiG , ChaimaniA , AtkinsonLZ , Ogawa Y et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet2018;391(10128):1357-66.">Cipriani 2018</a>; <a href="./references#CD008591-bbs2-0024" title="GartlehnerG , HansenRA , MorganL , ThalerK , LuxL , Van NoordM , et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Annals of Internal Medicine2011;155(11):772-85.">Gartlehner 2011</a>; <a href="./references#CD008591-bbs2-0043" title="MondenR , RoestAM , vanRavenzwaaijD , WagenmakersEJ , MoreyR , WardenaarKJ , et al. The comparative evidence basis for the efficacy of second-generation antidepressants in the treatment of depression in the US: a Bayesian meta-analysis of Food and Drug Administration reviews. Journal of Affective Disorders2018;235:393-8.">Monden 2018</a>; <a href="./references#CD008591-bbs2-0054" title="WagnerG , SchultesMT , TitscherV , TeuferB , KleringsI , GartlehnerG . Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: a systematic review and network meta-analysis. Journal of Affective Disorders2018;228(1):1-12.">Wagner 2018</a>). The original version of this review was published in 2011 and required an update (<a href="./references#CD008591-bbs2-0059" title="ThalerK , DelivukM , ChapmanA , GaynesBN , KaminskiA , GartlehnerG . Second-generation antidepressants for seasonal affective disorder. Cochrane Database of Systematic Reviews2011, Issue 12. Art. No: CD008591. [DOI: 10.1002/14651858.CD008591.pub2]">Thaler 2011</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD008591-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD008591-sec-0014"></div> <p>To assess the efficacy and safety of second‐generation antidepressants (SGAs) for the treatment of seasonal affective disorder (SAD) in adults in comparison with placebo, light therapy, other SGAs, or psychotherapy. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD008591-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD008591-sec-0015"></div> <section id="CD008591-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD008591-sec-0017"> <h4 class="title">Types of studies</h4> <section id="CD008591-sec-0018"> <h5 class="title">Efficacy (beneficial effects)</h5> <p>We included randomised controlled trials (RCTs) of at least four weeks' duration. We included cluster‐RCTs, with data from cross‐over trials eligible up to the point of crossing over. </p> </section> <section id="CD008591-sec-0019"> <h5 class="title">Adverse events</h5> <p>We included both experimental and observational (non‐randomised) studies (<a href="./references#CD008591-bbs2-0016" title="BarbuiC , EspositoE , CiprianiA . Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ: Canadian Medical Association Journal/Journal de l'Association Medicale Canadienne2009;180(3):291-7.">Barbui 2009</a>; <a href="./references#CD008591-bbs2-0034" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook.">Higgins 2020</a>): </p> <p> <ul id="CD008591-list-0001"> <li> <p>RCTs of SGAs for SAD, of at least four weeks' duration;</p> </li> <li> <p>controlled and uncontrolled non‐randomised studies of SGAs for SAD, of at least four weeks' duration. </p> </li> </ul> </p> </section> </section> <section id="CD008591-sec-0020"> <h4 class="title">Types of participants</h4> <p>We included studies involving adults (at least 18 years of age) with a DSM‐IV (<i>Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition</i>) (<a href="./references#CD008591-bbs2-0015" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (Text Revision). 4th edition. Washington, DC: American Psychiatric Association, 2000.">APA 2000</a>), or equivalent diagnosis of SAD (major depressive disorder (MDD) with a seasonal pattern). Studies that enrolled SAD participants with bipolar depression were excluded; because patients with bipolar disorders are primarily treated with mood stabilisers, not with antidepressants, while SGAs are the first line treatment for patients with unipolar depression. Studies with participants with secondary co‐morbidities were considered for inclusion. </p> </section> <section id="CD008591-sec-0021"> <h4 class="title">Types of interventions</h4> <section id="CD008591-sec-0022"> <h5 class="title">Experimental interventions</h5> <p>We considered trials of the following SGAs:</p> <p> <ul id="CD008591-list-0002"> <li> <p>SSRIs: citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline;</p> </li> <li> <p>SNRIs: desvenlafaxine, duloxetine, milnacipran, mirtazapine, venlafaxine;</p> </li> <li> <p>other: agomelatine, bupropion, nefazodone, reboxetine, trazodone, levomilnacipran, vilazodone, vortioxetine. </p> </li> </ul> </p> </section> <section id="CD008591-sec-0023"> <h5 class="title">Comparison interventions</h5> <p>We compared any SGA with another SGA, placebo, light therapy, or psychotherapy as a comparator. Commonly used psychological therapy approaches include behavioural therapy, cognitive behavioural therapy, and psychodynamic therapy. Placebo could be pills that look like an SGA but have no therapeutic value (sugar pill), or light therapy devices that emit little lux and therefore have no therapeutic value. </p> </section> </section> <section id="CD008591-sec-0024"> <h4 class="title">Types of outcome measures</h4> <section id="CD008591-sec-0025"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome is the proportion of participants achieving a clinical response, calculated from the number of participants randomised (intention‐to‐treat analysis). Clinical response was defined by the trial authors and included: </p> <p> <ol id="CD008591-list-0003"> <li> <p>the proportion of participants experiencing a greater than 50% improvement on the Hamilton Depression Scale (HAM‐D) (<a href="./references#CD008591-bbs2-0030" title="HamiltonM . Rating depressive patients. Journal of Clinical Psychiatry1980;41(12):21-4.">Hamilton 1980</a>), combined with the eight‐item supplementary scale for seasonal affective disorder (Structured Interview Guide for the Hamilton Depression Rating Scale ‐ Seasonal Affective Disorder Version (SIGH‐SAD)) (<a href="./references#CD008591-bbs2-0056" title="WilliamsJB . A structured interview guide for the Hamilton Depression Rating Scale. Archives of General Psychiatry1988;45(8):742-7.">Williams 1988</a>); </p> </li> <li> <p>the proportion of participants experiencing a greater than 50% improvement on the HAM‐D. </p> </li> </ol> </p> </section> <section id="CD008591-sec-0026"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD008591-list-0004"> <li> <p>Proportion of participants reporting a Clinical Global Impression – Improvement (CGI‐I) score of 1 or 2 (much improved or very much improved) (<a href="./references#CD008591-bbs2-0028" title="GuyW , BonatoRR . Manual for the ECDEU Assessment Battery. 2nd edition. Chevy Chase, MD: National Institute of Mental Health, 1970.">Guy 1970</a>). </p> </li> <li> <p>Improvement in quality of life (QOL), as measured by a validated QOL tool (e.g. 36‐item Short Form Health Survey (SF‐36)) (<a href="./references#CD008591-bbs2-0055" title="WareJE , SherbourneCD . The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care1992;30(6):473-83.">Ware 1992</a>). </p> </li> <li> <p>Remission, as defined by the study authors.</p> </li> <li> <p>Speed of onset of response.</p> </li> <li> <p>Occurrence of adverse events, such as suicidality (suicidal thinking or behaviour), sexual side effects, seizures, biochemical adverse events (e.g. hyponatraemia), weight change, and gastrointestinal symptoms, as well as withdrawals attributable to adverse events and serious adverse events. </p> </li> </ol> </p> </section> </section> </section> <section id="CD008591-sec-0027"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD008591-sec-0028"> <h4 class="title">Electronic searches</h4> <p>An Information Specialist with the Cochrane Common Mental Disorders Group ran an updated search on the following databases to identify reports of RCTs (29 January 2020) (<a href="./appendices#CD008591-sec-0093">Appendix 1</a>): </p> <p> <ul id="CD008591-list-0005"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2020, Issue 1) in the Cochrane Library (all years); </p> </li> <li> <p>Ovid MEDLINE (2011 to 29 January 2020);</p> </li> <li> <p>Ovid Embase (2011 to 29 January 2020);</p> </li> <li> <p>Ovid PsycINFO (2011 to 29 January 2020);</p> </li> <li> <p>Cochrane Common Mental Disorders Controlled Trials Register (CCMDCTR) (archived database) (2011 to June 2016 only). </p> </li> </ul> </p> <p>International trial protocols registered on the US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) were captured via CENTRAL on the Cochrane Library. </p> <p>The Information Specialist also ran a separate search for adverse events (Ovid databases) (24 February 2020) (<a href="./appendices#CD008591-sec-0094">Appendix 2</a>). </p> <p>We applied no restrictions to language or publication status.</p> <p>Searches for the earlier version of this review, published in 2011, are shown in <a href="./appendices#CD008591-sec-0095">Appendix 3</a>. </p> </section> <section id="CD008591-sec-0029"> <h4 class="title">Searching other resources</h4> <p>In addition, we handsearched the references of all included studies and pertinent review articles. We ran a separate search of the US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov/</a>) to detect ongoing or unpublished studies. Finally, we contacted experts in the field of SAD to ensure that we were aware of all published and unpublished trials. </p> </section> </section> <section id="CD008591-sec-0030"> <h3 class="title" id="CD008591-sec-0030">Data collection and analysis</h3> <section id="CD008591-sec-0031"> <h4 class="title">Selection of studies</h4> <p>Two review authors (BNS, KT, AC, TP, AS, or GG) independently reviewed the titles and abstracts of records identified by the search. We retrieved full‐text copies of all studies that potentially met the inclusion criteria based on abstract review, and two review authors (BNS, KT, AC, TP, AS, or GG) independently reviewed these to determine their eligibility. Any disagreements between review authors were discussed with and resolved by a third party (BNS or GG). We used Covidence software to facilitate title/abstract and full‐text screening (<a href="./references#CD008591-bbs2-0020" title="Covidence systematic review software. Melbourne, Australia: Veritas Health Innovation, 2019. Available at www.covidence.org.">Covidence</a>). </p> <p>No studies published only as abstracts were considered for inclusion in the review, hence there was no need to contact trial authors for information required to permit an appraisal of trial quality. </p> </section> <section id="CD008591-sec-0032"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (BNS, KT) independently abstracted data from the included trials. A third review author (AC) checked the data for accuracy and completeness. Any discrepancies were resolved by consensus or by involving a third review author. </p> <p>We extracted the following study characteristics.</p> <p> <ul id="CD008591-list-0006"> <li> <p>Methods: study design, duration of study, duration of treatment period, number of study centres, Country. </p> </li> <li> <p>Participants: number of participants, age (mean or range), proportion of women, diagnostic criteria, inclusion and exclusion criteria. </p> </li> <li> <p>Interventions: intervention, comparison.</p> </li> <li> <p>Outcomes: primary and secondary outcomes specified.</p> </li> <li> <p>Notes: funding for studies and conflicts of interest of authors.</p> </li> </ul> </p> <p>All possible comparisons based on our inclusion criteria were as follows.</p> <p> <ol id="CD008591-list-0007"> <li> <p>SGAs versus placebo</p> </li> <li> <p>SGAs versus light therapy</p> </li> <li> <p>SGAs versus other SGAs</p> </li> <li> <p>SGAs versus psychotherapy</p> </li> </ol> </p> <p>In the case of missing data, we would have contacted the study authors, but this was not necessary. </p> </section> <section id="CD008591-sec-0033"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the risk of bias of randomised trials using the Cochrane 'Risk of bias' tool, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008591-bbs2-0033" title="HigginsJPT , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions 5.0.2 (updated September 2009). The Cochrane Collaboration, 2009. Available from training.cochrane.org/handbook/archive/v5.0.2/.">Higgins 2009</a>). The tool includes assessment of: random sequence generation; allocation concealment; blinding of participants, personnel, and outcome assessors; incomplete outcome data; selective outcome reporting; and other potential threats to validity. Specifically, we assessed attrition (loss of participants during a study) in the trials and the reasons for it, particularly where the attrition rates between two groups in a trial were substantially different. In addition, we assessed whether all relevant outcomes for the trial were reported in the published articles. We assessed each domain as low, high, or unclear risk of bias. </p> <p>For non‐randomised studies, we used criteria involving selection of cases or cohorts and controls, adjustment for confounders, methods of outcomes assessment, length of follow‐up, and statistical analysis (<a href="./references#CD008591-bbs2-0021" title="DeeksJJ , DinnesJ , D'AmicoR , SowdenAJ , SakarovitchC , SongF , et al. Evaluating non-randomised intervention studies. Health Technology Assessment2003;7(27):1-173.">Deeks 2003</a>). We entered our 'Risk of bias' assessment into the standard 'Risk of bias' tables (used to generate figures in the report), as well as in an Additional table (<a href="#CD008591-tbl-0003">Table 1</a>; <a href="#CD008591-tbl-0004">Table 2</a>; <a href="#CD008591-tbl-0005">Table 3</a>; <a href="#CD008591-tbl-0006">Table 4</a>; <a href="#CD008591-tbl-0007">Table 5</a>). Two review authors (BNS, KT) independently assessed the risk of bias. Any discrepancies were resolved by consensus or by involving a third review author. </p> <div class="table" id="CD008591-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">'Risk of bias' table (non‐randomised study), Dilsaver 1992</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Domain</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Authors' judgement</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Support for judgement</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>How did allocation occur? Was there concealment of allocation?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All participants received active therapy with bupropion. No concealment of allocation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blinding? (participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Open‐label</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Follow‐up equal and complete?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33% attrition</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline comparability of groups?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 group</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intention‐to‐treat analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intention‐to‐treat analysis not employed.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly described.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome of interest (adverse events) not clearly specified.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interpretation based on results?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD008591-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">'Risk of bias' table (non‐randomised study), Pjrek 2007</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Domain</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Authors' judgement</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Support for judgement</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>How did allocation occur? Was there concealment of allocation?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All participants received active therapy with escitalopram. No concealment of allocation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blinding? (participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Open‐label</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Follow‐up equal and complete?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10% attrition</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline comparability of groups?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 group</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intention‐to‐treat analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intention‐to‐treat analysis employed.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly described.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified, including prospective adverse events recording with Udvalg for Kliniske Undersogelser<br/>(UKU) Side Effect Rating Scale. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interpretation based on results?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD008591-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">'Risk of bias' table (non‐randomised study), Pjrek 2008</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Domain</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Authors' judgement</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Support for judgement</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>How did allocation occur? Was there concealment of allocation?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All participants received active therapy with duloxetine. No concealment of allocation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blinding? (participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Open‐label</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Follow‐up equal and complete?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23% attrition</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline comparability of groups?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 group</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intention‐to‐treat analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LOCF analysis employed.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly described.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified, including prospective adverse events recording with Udvalg for Kliniske Undersogelser<br/>(UKU) Side Effect Rating Scale. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interpretation based on results?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No, due to high attrition and use of LOCF approach for missing data</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>LOCF: last observation carried forward</p> </div> </div> <div class="table" id="CD008591-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">'Risk of bias' table (non‐randomised study), Pjrek 2009</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Domain</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Authors' judgement</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Support for judgement</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>How did allocation occur? Was there concealment of allocation?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All participants received active therapy with reboxetine. No concealment of allocation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blinding? (participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Open‐label</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Follow‐up equal and complete?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27% attrition</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline comparability of groups?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 group</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intention‐to‐treat analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LOCF analysis employed.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly described.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified, including prospective adverse events recording with Udvalg for Kliniske Undersogelser<br/>(UKU) Side Effect Rating Scale. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interpretation based on results?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No, due to high attrition and use of LOCF approach for missing data</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>LOCF: last observation carried forward</p> </div> </div> <div class="table" id="CD008591-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">'Risk of bias' table (non‐randomised study), Shen 2005</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Domain</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Authors' judgement</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Support for judgement</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>How did allocation occur? Was there concealment of allocation?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All participants received active therapy with nefazodone. No concealment of allocation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blinding? (participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Open‐label</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Follow‐up equal and complete?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33% attrition</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline comparability of groups?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 group</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intention‐to‐treat analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No intention‐to‐treat analysis employed.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly described.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For adverse events a questionnaire was used (no details about the questionnaire).</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interpretation based on results?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events are reported vaguely without presentation of absolute numbers.</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD008591-sec-0034"> <h4 class="title">Measures of treatment effect</h4> <p>We used the extracted data from the original studies to construct 2 x 2 tables (e.g. clinical response versus no response for antidepressant versus comparator). Where multiple studies allowed for pooling, we calculated the risk ratio (RR) with 95% confidence intervals (CI) for each outcome. We planned to calculate the number needed to treat for an additional beneficial outcome (NNTB) and risk difference (RD). In addition, we planned to pool continuous data using the mean difference (MD) or standardised mean difference (SMD). </p> </section> <section id="CD008591-sec-0035"> <h4 class="title">Unit of analysis issues</h4> <p>For any included trials with multiple treatment groups (e.g. differing doses of one SGA versus placebo or multiple SGAs versus placebo), we would include the data for the treatment arms and halve the data from the placebo arm, or collapse the data for different doses into one group where this was considered to be clinically appropriate (<a href="./references#CD008591-bbs2-0031" title="HansenRA , MooreCG , DusetzinaSB , LeinwandBI , GartlehnerG , GaynesB . Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose. Medical Decision Making2009;29(1):91-103.">Hansen 2009</a>). We planned to include data from cluster‐randomised studies and from the first period of cross‐over studies. </p> </section> <section id="CD008591-sec-0036"> <h4 class="title">Dealing with missing data</h4> <p>We used an intention‐to‐treat analysis where data were missing from participants who dropped out of trials before completion, assuming in such cases that participants did not achieve a clinical response or remission. We planned that where data regarding an assessed outcome were not reported, we would contact authors of publications or pharmaceutical companies to obtain the missing results, but this was not necessary. We have reported the proportion of participants for whom no outcome data were obtained (because of attrition) in the 'Risk of bias' assessment of each trial, and considered the potential impact of the missing data in our interpretation of the results. </p> </section> <section id="CD008591-sec-0037"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the Cochran Chi<sup>2</sup> test (Q‐test) to assess heterogeneity, considering a P value less than 0.10 as statistically significant. We used the I<sup>2</sup> statistic to estimate the degree of heterogeneity, which describes the percentage of total variation across studies that results from heterogeneity rather than chance. We interpreted the importance of any heterogeneity in terms of its magnitude and the direction of effects. We did not consider thresholds, instead adopting the overlapping bands suggested in the <i>Cochrane Handbook</i>. For example, we considered an I<sup>2</sup> of: </p> <p> <ul id="CD008591-list-0008"> <li> <p>0% to 40% as probably not important;</p> </li> <li> <p>30% to 60% as representing moderate heterogeneity;</p> </li> <li> <p>50% to 90% as substantial heterogeneity;</p> </li> <li> <p>75% to 100% as considerable heterogeneity (<a href="./references#CD008591-bbs2-0034" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook.">Higgins 2020</a>). </p> </li> </ul> </p> </section> <section id="CD008591-sec-0038"> <h4 class="title">Assessment of reporting biases</h4> <p>Had we found more than 10 studies, we would have undertaken an analysis of a funnel plot, which is a graph used to detect publication bias. We wanted to know whether the largest studies were near the average with small studies spread on both sides of the average. Variations from this assumption can indicate the existence of publication bias, but asymmetry may not necessarily be caused by publication bias. </p> </section> <section id="CD008591-sec-0039"> <h4 class="title">Data synthesis</h4> <p>We analysed data using Review Manager 5 (<a href="./references#CD008591-bbs2-0051" title="Review Manager (RevMan). Version 5.4. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2020.">Review Manager 2020</a>). We pooled data for meta‐analysis where the participant groups were similar, and the studies assessed the same treatments with the same comparator and had similar definitions of outcome measures over a similar duration of treatment. We used a fixed‐effect model because we expected studies to be very similar. Studies reporting dichotomous data were weighted using the Mantel‐Haenszel method. We rated the strength of the evidence based on the system developed by the GRADE Working Group (<a href="./references#CD008591-bbs2-0029" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383-94.">Guyatt 2011</a>). </p> <p>We performed a narrative analysis of data on adverse events comparing crude rates. We planned to conduct quantitative analysis of the rate of adverse events only if we located a sufficient number of prospective observational studies or randomised trials that contained data on adverse events suitable for pooling. </p> </section> <section id="CD008591-sec-0040"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to perform subgroup analyses of SSRIs and SNRIs, but this was not possible due to the limited number of identified studies. </p> </section> <section id="CD008591-sec-0041"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analysis using a random‐effects model  to see if this would change the pooled results. We planned to conduct additional sensitivity analyses excluding small studies, studies with a high risk of bias, and studies published in abstract form; however, due to the limited number of trials available it was not possible to perform these analyses. </p> </section> <section id="CD008591-sec-0042"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>Two review authors (BNS, KT) assessed the certainty of evidence using the GRADE approach, which considers risk of bias, inconsistency, indirectness, imprecision, and publication bias for each outcome. Evidence from RCTs starts at a level of high certainty. Concerns about any of the aforementioned domains would result in downgrading of the evidence by one or two levels; explanations for our decisions would be provided in the 'Summary of findings' tables. For example, we would downgrade one level for imprecision if the 95% CI included both a beneficial or non‐beneficial effect. We assessed the certainty of the evidence as high, moderate, low, or very low according to the GRADE approach (<a href="./references#CD008591-bbs2-0029" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383-94.">Guyatt 2011</a>). We created two 'Summary of findings' tables, one for the comparison SGAs versus placebo (<a href="./full#CD008591-tbl-0001">summary of findings Table 1</a>), and one for SGAs versus light therapy (<a href="./full#CD008591-tbl-0002">summary of findings Table 2</a>). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD008591-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD008591-sec-0043"></div> <section id="CD008591-sec-0044"> <h3 class="title">Description of studies</h3> <section id="CD008591-sec-0045"> <h4 class="title">Results of the search</h4> <p>We conducted searches for efficacy and for adverse events separately. The 2020 update search retrieved 168 records for efficacy and 179 records for adverse events. After additional de‐duplication in Covidence, 295 records remained for screening. We considered 29 citations to be relevant after title and abstract screening. We obtained all 29 full‐text publications, of which 25 were excluded for the following reasons: ineligible study design (15 articles), ineligible population (5 articles), wrong intervention (1 article), wrong outcomes (1 article), and duplicates of records already included in the original version of this review (3 articles). For detailed information on the results of the search of the original review, see <a href="./references#CD008591-bbs2-0059" title="ThalerK , DelivukM , ChapmanA , GaynesBN , KaminskiA , GartlehnerG . Second-generation antidepressants for seasonal affective disorder. Cochrane Database of Systematic Reviews2011, Issue 12. Art. No: CD008591. [DOI: 10.1002/14651858.CD008591.pub2]">Thaler 2011</a>. Finally, we included three RCTs (five publications) that had already been included in the original version of this review (<a href="./references#CD008591-bbs2-0002" title="LamR , GormanC , MichalonM , SteinerM , LevittA , CorralM , et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. American Journal of Psychiatry1995;152(12):1765-70. ">Lam 1995</a>; <a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>; <a href="./references#CD008591-bbs2-0007" title="RuhrmannS , KasperS , HawellekB , MartinezB , HöflichG , NickelsonT , et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychological Medicine1998;28:923-33. RuhrmannS , KasperS , HawellekB , MartinezB , HoflichG , NickelsenT , et al. Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder (SAD) [abstract]. Pharmacopsychiatry [abstracts from the 18th Symposium of AGNP, Nuremberg 1993]1993;26:193. RuhrmannS , KasperS , HawellekB , PetersS , RaoML , HoflichG , et al. Selective serotonin re-uptake inhibitors for treatment of seasonal affective disorder (SAD) [poster abstract]. Clinical Neuropharmacology1992;15(Suppl 1, Pt B):341. ">Ruhrmann 1998</a>), and five observational studies providing additional information on adverse events (eight publications) (<a href="./references#CD008591-bbs2-0001" title="DilsaverSC , QamarAB , Del MedicoVJ . The efficacy of bupropion in winter depression: results of an open trial. Journal of Clinical Psychiatry1992;53(7):252-5. ">Dilsaver 1992</a>; <a href="./references#CD008591-bbs2-0004" title="PjrekE , KonstantinidisA , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine. European Neuropsychopharmacology2009;19 Suppl 3:S404. PjrekE , WinklerD , StastnyJ , Praschak-RiederN , WilleitM , KasperS . Escitalopram in seasonal affective disorder: results of an open trial. Pharmacopsychiatry2007;40(1):20-4. ">Pjrek 2007</a>; <a href="./references#CD008591-bbs2-0005" title="PjrekE , WilleitM , Praschak-RiederN , KonstantinidisH , SemlitschH , KasperS , et al. Treatment of seasonal affective disorder with duloxetine: an open-label study. Pharmacopsychiatry2008;41(3):100-5. ">Pjrek 2008</a>; <a href="./references#CD008591-bbs2-0006" title="HilgerE , WilleitM , Praschak-RiederN , StastnyJ , NeumeisterA , KasperS . Reboxetine in seasonal affective disorder: an open trial. European Neuropsychopharmacology2001;11:1-5. PjrekE , KonstantinidisA , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine. European Neuropsychopharmacology2009;19 Suppl 3:S404. PjrekE , KonstantinidisH , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis. Journal of Psychiatric Research2009;43:792-7. PjrekE , WinklerD , StastnyJ , Praschak-RiederN , WilleitM , KasperS . Escitalopram in seasonal affective disorder: results of an open trial. Pharmacopsychiatry2007;40(1):20-4. ">Pjrek 2009</a>; <a href="./references#CD008591-bbs2-0008" title="ShenJ , KennedySH , LevitanRD , KayumovL , ShapiroCM . The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. Journal of Psychiatry &amp; Neuroscience2005;30(1):11-6. ">Shen 2005</a>) (see <a href="#CD008591-fig-0001">Figure 1</a>). <a href="./references#CD008591-bbs2-0001" title="DilsaverSC , QamarAB , Del MedicoVJ . The efficacy of bupropion in winter depression: results of an open trial. Journal of Clinical Psychiatry1992;53(7):252-5. ">Dilsaver 1992</a> and <a href="./references#CD008591-bbs2-0008" title="ShenJ , KennedySH , LevitanRD , KayumovL , ShapiroCM . The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. Journal of Psychiatry &amp; Neuroscience2005;30(1):11-6. ">Shen 2005</a> were newly identified in this update.  </p> <div class="figure" id="CD008591-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD008591-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD008591-sec-0046"> <h4 class="title">Included studies</h4> <section id="CD008591-sec-0047"> <h5 class="title">Randomised controlled trials</h5> <p>We included three RCTs of an SGA versus placebo or light therapy for SAD (<a href="./references#CD008591-bbs2-0002" title="LamR , GormanC , MichalonM , SteinerM , LevittA , CorralM , et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. American Journal of Psychiatry1995;152(12):1765-70. ">Lam 1995</a>; <a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>; <a href="./references#CD008591-bbs2-0007" title="RuhrmannS , KasperS , HawellekB , MartinezB , HöflichG , NickelsonT , et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychological Medicine1998;28:923-33. RuhrmannS , KasperS , HawellekB , MartinezB , HoflichG , NickelsenT , et al. Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder (SAD) [abstract]. Pharmacopsychiatry [abstracts from the 18th Symposium of AGNP, Nuremberg 1993]1993;26:193. RuhrmannS , KasperS , HawellekB , PetersS , RaoML , HoflichG , et al. Selective serotonin re-uptake inhibitors for treatment of seasonal affective disorder (SAD) [poster abstract]. Clinical Neuropharmacology1992;15(Suppl 1, Pt B):341. ">Ruhrmann 1998</a>). The three trials included a total of 204 participants and provided evidence on two comparisons: </p> <p> <ul id="CD008591-list-0009"> <li> <p>fluoxetine versus placebo (68 participants) (<a href="./references#CD008591-bbs2-0002" title="LamR , GormanC , MichalonM , SteinerM , LevittA , CorralM , et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. American Journal of Psychiatry1995;152(12):1765-70. ">Lam 1995</a>); </p> </li> <li> <p>fluoxetine versus light therapy (136 participants) (<a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>; <a href="./references#CD008591-bbs2-0007" title="RuhrmannS , KasperS , HawellekB , MartinezB , HöflichG , NickelsonT , et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychological Medicine1998;28:923-33. RuhrmannS , KasperS , HawellekB , MartinezB , HoflichG , NickelsenT , et al. Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder (SAD) [abstract]. Pharmacopsychiatry [abstracts from the 18th Symposium of AGNP, Nuremberg 1993]1993;26:193. RuhrmannS , KasperS , HawellekB , PetersS , RaoML , HoflichG , et al. Selective serotonin re-uptake inhibitors for treatment of seasonal affective disorder (SAD) [poster abstract]. Clinical Neuropharmacology1992;15(Suppl 1, Pt B):341. ">Ruhrmann 1998</a>). </p> </li> </ul> </p> <p>The trials had a treatment duration of five to eight weeks, and all trials incorporated an initial placebo wash‐out period. Two trials were sponsored by pharmaceutical companies (<a href="./references#CD008591-bbs2-0002" title="LamR , GormanC , MichalonM , SteinerM , LevittA , CorralM , et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. American Journal of Psychiatry1995;152(12):1765-70. ">Lam 1995</a>; <a href="./references#CD008591-bbs2-0007" title="RuhrmannS , KasperS , HawellekB , MartinezB , HöflichG , NickelsonT , et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychological Medicine1998;28:923-33. RuhrmannS , KasperS , HawellekB , MartinezB , HoflichG , NickelsenT , et al. Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder (SAD) [abstract]. Pharmacopsychiatry [abstracts from the 18th Symposium of AGNP, Nuremberg 1993]1993;26:193. RuhrmannS , KasperS , HawellekB , PetersS , RaoML , HoflichG , et al. Selective serotonin re-uptake inhibitors for treatment of seasonal affective disorder (SAD) [poster abstract]. Clinical Neuropharmacology1992;15(Suppl 1, Pt B):341. ">Ruhrmann 1998</a>), and one trial was funded by the Canadian Institute of Health Research (<a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>). </p> <p>Trials were generally small (40 to 96 participants) and recruited participants in Canada and Germany. All participants met DSM‐III‐R (<i>Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised</i>) or DSM‐IV criteria for depression with a seasonal pattern. Trials typically had more females than males (66% to 78% females), and the average age ranged from 39 to 41 years. </p> <p>All SGAs were prescribed orally and taken at recommended doses. Light therapy was at 3000 lux or 10,000 lux. </p> <p>All trials provided data on the HAM‐D 17‐item or 21‐item, with the supplementary seven‐ or eight‐item subscale for SAD (SIGH‐SAD or SUPP). One trial provided quality of life data (<a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>). </p> </section> <section id="CD008591-sec-0048"> <h5 class="title">Non‐randomised studies</h5> <p>We also included five prospective, single‐arm, open‐label observational studies of bupropion, escitalopram, duloxetine, nefazodone, and reboxetine for data on adverse events. These studies included between 9 and 26 participants and recruited participants with a DSM‐III‐R or DSM‐IV‐TR (<i>Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision</i>) diagnosis of SAD at the Medical University of Vienna, Austria, in the USA, and in Canada. The studies lasted five (<a href="./references#CD008591-bbs2-0001" title="DilsaverSC , QamarAB , Del MedicoVJ . The efficacy of bupropion in winter depression: results of an open trial. Journal of Clinical Psychiatry1992;53(7):252-5. ">Dilsaver 1992</a>), six (<a href="./references#CD008591-bbs2-0006" title="HilgerE , WilleitM , Praschak-RiederN , StastnyJ , NeumeisterA , KasperS . Reboxetine in seasonal affective disorder: an open trial. European Neuropsychopharmacology2001;11:1-5. PjrekE , KonstantinidisA , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine. European Neuropsychopharmacology2009;19 Suppl 3:S404. PjrekE , KonstantinidisH , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis. Journal of Psychiatric Research2009;43:792-7. PjrekE , WinklerD , StastnyJ , Praschak-RiederN , WilleitM , KasperS . Escitalopram in seasonal affective disorder: results of an open trial. Pharmacopsychiatry2007;40(1):20-4. ">Pjrek 2009</a>), or eight weeks (<a href="./references#CD008591-bbs2-0004" title="PjrekE , KonstantinidisA , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine. European Neuropsychopharmacology2009;19 Suppl 3:S404. PjrekE , WinklerD , StastnyJ , Praschak-RiederN , WilleitM , KasperS . Escitalopram in seasonal affective disorder: results of an open trial. Pharmacopsychiatry2007;40(1):20-4. ">Pjrek 2007</a>; <a href="./references#CD008591-bbs2-0005" title="PjrekE , WilleitM , Praschak-RiederN , KonstantinidisH , SemlitschH , KasperS , et al. Treatment of seasonal affective disorder with duloxetine: an open-label study. Pharmacopsychiatry2008;41(3):100-5. ">Pjrek 2008</a>; <a href="./references#CD008591-bbs2-0008" title="ShenJ , KennedySH , LevitanRD , KayumovL , ShapiroCM . The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. Journal of Psychiatry &amp; Neuroscience2005;30(1):11-6. ">Shen 2005</a>). About 70% to 100% of participants were female, and the average age ranged from 34 to 42 years. Adverse events were recorded weekly or bi‐weekly using the Udvalg for Kliniske Undersogelser (UKU) Side Effect Rating Scale (<a href="./references#CD008591-bbs2-0004" title="PjrekE , KonstantinidisA , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine. European Neuropsychopharmacology2009;19 Suppl 3:S404. PjrekE , WinklerD , StastnyJ , Praschak-RiederN , WilleitM , KasperS . Escitalopram in seasonal affective disorder: results of an open trial. Pharmacopsychiatry2007;40(1):20-4. ">Pjrek 2007</a>; <a href="./references#CD008591-bbs2-0005" title="PjrekE , WilleitM , Praschak-RiederN , KonstantinidisH , SemlitschH , KasperS , et al. Treatment of seasonal affective disorder with duloxetine: an open-label study. Pharmacopsychiatry2008;41(3):100-5. ">Pjrek 2008</a>; <a href="./references#CD008591-bbs2-0006" title="HilgerE , WilleitM , Praschak-RiederN , StastnyJ , NeumeisterA , KasperS . Reboxetine in seasonal affective disorder: an open trial. European Neuropsychopharmacology2001;11:1-5. PjrekE , KonstantinidisA , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine. European Neuropsychopharmacology2009;19 Suppl 3:S404. PjrekE , KonstantinidisH , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis. Journal of Psychiatric Research2009;43:792-7. PjrekE , WinklerD , StastnyJ , Praschak-RiederN , WilleitM , KasperS . Escitalopram in seasonal affective disorder: results of an open trial. Pharmacopsychiatry2007;40(1):20-4. ">Pjrek 2009</a>), or collected with a self‐reported questionnaire (<a href="./references#CD008591-bbs2-0008" title="ShenJ , KennedySH , LevitanRD , KayumovL , ShapiroCM . The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. Journal of Psychiatry &amp; Neuroscience2005;30(1):11-6. ">Shen 2005</a>), or unsystematically assessed without specifying the exact method of assessment (<a href="./references#CD008591-bbs2-0001" title="DilsaverSC , QamarAB , Del MedicoVJ . The efficacy of bupropion in winter depression: results of an open trial. Journal of Clinical Psychiatry1992;53(7):252-5. ">Dilsaver 1992</a>). </p> <p>For further details on the included studies, see <a href="./references#CD008591-sec-0107" title="">Characteristics of included studies</a>. </p> </section> </section> <section id="CD008591-sec-0049"> <h4 class="title">Excluded studies</h4> <p>Overall, we excluded 33 studies on full‐text level in the original review, and 25 in this update. In the following section we provide detailed exclusion reasons only for those records that a reader might plausibly expect to see amongst the included studies. </p> <p>We excluded three studies where participants were randomised to bupropion or placebo for the <i>prevention</i> of SAD because the population did not meet our inclusion criteria (<a href="./references#CD008591-bbs2-0009" title="GlaxoSmithKline. A 7-month, multicenter, randomized, double-blind, placebo-controlled comparison of 150-300 mg/day of extended-release bupropion hydrochloride (WELLBUTRIN XL) and placebo for the prevention of seasonal affective disorder in subjects with a history of seasonal affective disorder followed by an 8-Week observational follow-up phase. www.gsk-clinicalstudyregister.com. [WELL AK130930]">GlaxoSmithKline 2003</a>; <a href="./references#CD008591-bbs2-0010" title="GlaxoSmithKline. A 7-month, multicenter, randomized, double-blind, placebo-controlled comparison of 150-300 mg/day of extended-release bupropion hydrochloride (WELLBUTRIN XL) and placebo for the prevention of seasonal affective disorder in subjects with a history of seasonal affective disorder followed by an 8-week observational follow-up phase. www.gsk-clinicalstudyregister.com. [WELL AK130936]">GlaxoSmithKline 2003a</a>; <a href="./references#CD008591-bbs2-0011" title="GlaxoSmithKline. A 7-month, multicenter, randomized, double-blind, placebo-controlled comparison of 150-300 mg/day of extended-release bupropion hydrochloride (WELLBUTRIN XL) and placebo for the prevention of seasonal affective disorder in subjects with a history of seasonal affective disorder followed by an 8-week observational follow-up study. www.gsk-clinicalstudyregister.com. [WELL 100006]">GlaxoSmithKline 2004</a>), that is the participants did not have symptoms of SAD at the time of enrolment. </p> <p>We excluded two studies because the population did not meet our inclusion criteria (<a href="./references#CD008591-bbs2-0012" title="BlashkoC . A double-blind, placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder. In: 8th ECNP (European College of Neuropsychopharmacology) Congress; 1995 09 30 - 10 04; Venice, Italy. Venice, Italy: European College of Neuropsychopharmacology, 1995. BlashkoC . Drug treatment of winter depression: How effective is it, and what can it tell us about the biology of SAD? In: Sixth World Congress of Biological Psychiatry; 1997 06 22-27, Nice, France. Nice, France: World Federation of the Societies of Biological Psychiatry, 1997. MoscovitchA , BlashkoC , EaglesJ , DarcoutG , ThompsonC , KasperS , et al. A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder. Psychopharmacology2004;171(4):390-7. ">Moscovitch 2004</a>; <a href="./references#CD008591-bbs2-0014" title="SeoHJ , LeeBC , SeokJH , JeonHJ , PaikJW , KimW , et al. An open-label, rater-blinded, 8-week trial of bupropion hydrochloride extended-release in patients with major depressive disorder with atypical features. Pharmacopsychiatry2013;46(6):221-6. ">Seo 2013</a>). One study was reported in a journal article and two conference abstracts. The study was a multicentre, eight‐week, randomised trial of sertraline versus placebo in 187 participants with a DSM‐III‐R diagnosis of major depression or <i>bipolar disorder</i> with a seasonal pattern, which did not meet our inclusion criteria (<a href="./references#CD008591-bbs2-0012" title="BlashkoC . A double-blind, placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder. In: 8th ECNP (European College of Neuropsychopharmacology) Congress; 1995 09 30 - 10 04; Venice, Italy. Venice, Italy: European College of Neuropsychopharmacology, 1995. BlashkoC . Drug treatment of winter depression: How effective is it, and what can it tell us about the biology of SAD? In: Sixth World Congress of Biological Psychiatry; 1997 06 22-27, Nice, France. Nice, France: World Federation of the Societies of Biological Psychiatry, 1997. MoscovitchA , BlashkoC , EaglesJ , DarcoutG , ThompsonC , KasperS , et al. A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder. Psychopharmacology2004;171(4):390-7. ">Moscovitch 2004</a>). The second trial assessed the effect of bupropion hydrochloride extended‐release in people with major depressive disorder with atypical features not specifically in people with SAD (<a href="./references#CD008591-bbs2-0014" title="SeoHJ , LeeBC , SeokJH , JeonHJ , PaikJW , KimW , et al. An open-label, rater-blinded, 8-week trial of bupropion hydrochloride extended-release in patients with major depressive disorder with atypical features. Pharmacopsychiatry2013;46(6):221-6. ">Seo 2013</a>). </p> <p>Finally, a six‐week study of 183 participants with major depression randomised to 20 to 40 mg/day of fluoxetine or 300 to 450 mg/day of moclobemide presented separate results for the 34 SAD participants included in the trial (<a href="./references#CD008591-bbs2-0013" title="PartonenT , LönnqvistJ . Moclobemide and fluoxetine in treatment of seasonal affective disorder. Journal of Affective Disorders1996;41(2):93-9. ">Partonen 1996</a>). We excluded this study because the comparator was moclobemide (our eligibility criteria specified we would only include comparisons with other SGAs, light therapy, psychotherapy, or placebo). </p> <p>For further information regarding the excluded studies, see <a href="./references#CD008591-sec-0108" title="">Characteristics of excluded studies</a>. </p> <section id="CD008591-sec-0050"> <h5 class="title">Ongoing studies</h5> <p>We did not identify any ongoing studies.</p> </section> </section> </section> <section id="CD008591-sec-0051"> <h3 class="title">Risk of bias in included studies</h3> <p>Whilst one well‐conducted and well‐reported trial had an overall low risk of bias (<a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>), overall the risk of bias in the included RCTs was high. The major source of bias was incomplete outcome data (high overall or differential attrition). The risk of bias in the non‐randomised studies (assessed using the Cochrane 'Risk of bias' tool and the <a href="./references#CD008591-bbs2-0021" title="DeeksJJ , DinnesJ , D'AmicoR , SowdenAJ , SakarovitchC , SongF , et al. Evaluating non-randomised intervention studies. Health Technology Assessment2003;7(27):1-173.">Deeks 2003</a> criteria) was high, primarily due to small sample size, lack of blinding, and high attrition. See <a href="./references#CD008591-sec-0107" title="">Characteristics of included studies</a> for further details on the risk of bias of the included studies, and <a href="#CD008591-fig-0002">Figure 2</a> and <a href="#CD008591-fig-0003">Figure 3</a> for an overview of the risk of bias. </p> <div class="figure" id="CD008591-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD008591-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD008591-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD008591-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>In the following section we describe the risk of bias for the three included RCTs. Details on risk of bias for the non‐randomised studies are provided in <a href="#CD008591-sec-0056">Other potential sources of bias</a>. </p> <section id="CD008591-sec-0052"> <h4 class="title">Allocation</h4> <p>One trial described computer‐generated randomisation techniques and was assessed as at low risk of bias for random sequence generation (<a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>). Otherwise, the method of random sequence generation was not described. Similarly, an adequate method of allocation concealment (using opaque envelopes) was reported in only one trial (<a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>), which was assessed as at low risk of bias. </p> </section> <section id="CD008591-sec-0053"> <h4 class="title">Blinding</h4> <p>All three trials were described as 'double‐blind'. In the two trials that compared an SGA with light therapy, the authors went to great lengths to maintain the blinding of participants in the placebo light‐therapy treatment by disguising the dim light control or by informing participants that the purpose of the trial was to determine the appropriate wavelength of light (<a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>; <a href="./references#CD008591-bbs2-0007" title="RuhrmannS , KasperS , HawellekB , MartinezB , HöflichG , NickelsonT , et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychological Medicine1998;28:923-33. RuhrmannS , KasperS , HawellekB , MartinezB , HoflichG , NickelsenT , et al. Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder (SAD) [abstract]. Pharmacopsychiatry [abstracts from the 18th Symposium of AGNP, Nuremberg 1993]1993;26:193. RuhrmannS , KasperS , HawellekB , PetersS , RaoML , HoflichG , et al. Selective serotonin re-uptake inhibitors for treatment of seasonal affective disorder (SAD) [poster abstract]. Clinical Neuropharmacology1992;15(Suppl 1, Pt B):341. ">Ruhrmann 1998</a>); furthermore, the blinding of raters (assessors) was clearly described. We assessed these two trials as at low risk of performance and detection bias. </p> </section> <section id="CD008591-sec-0054"> <h4 class="title">Incomplete outcome data</h4> <p>In one trial of fluoxetine versus light therapy, there was a high rate of differential attrition: 20% in the bright‐light group compared with 5% in the fluoxetine group (<a href="./references#CD008591-bbs2-0007" title="RuhrmannS , KasperS , HawellekB , MartinezB , HöflichG , NickelsonT , et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychological Medicine1998;28:923-33. RuhrmannS , KasperS , HawellekB , MartinezB , HoflichG , NickelsenT , et al. Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder (SAD) [abstract]. Pharmacopsychiatry [abstracts from the 18th Symposium of AGNP, Nuremberg 1993]1993;26:193. RuhrmannS , KasperS , HawellekB , PetersS , RaoML , HoflichG , et al. Selective serotonin re-uptake inhibitors for treatment of seasonal affective disorder (SAD) [poster abstract]. Clinical Neuropharmacology1992;15(Suppl 1, Pt B):341. ">Ruhrmann 1998</a>). We assessed this trial as at high risk of attrition bias. </p> </section> <section id="CD008591-sec-0055"> <h4 class="title">Selective reporting</h4> <p>None of the trials had a protocol available; however, all trials provided detailed reporting of the results as described in the respective methods sections. </p> </section> <section id="CD008591-sec-0056"> <h4 class="title">Other potential sources of bias</h4> <p>All five observational studies were conducted prospectively (<a href="./references#CD008591-bbs2-0001" title="DilsaverSC , QamarAB , Del MedicoVJ . The efficacy of bupropion in winter depression: results of an open trial. Journal of Clinical Psychiatry1992;53(7):252-5. ">Dilsaver 1992</a>; <a href="./references#CD008591-bbs2-0004" title="PjrekE , KonstantinidisA , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine. European Neuropsychopharmacology2009;19 Suppl 3:S404. PjrekE , WinklerD , StastnyJ , Praschak-RiederN , WilleitM , KasperS . Escitalopram in seasonal affective disorder: results of an open trial. Pharmacopsychiatry2007;40(1):20-4. ">Pjrek 2007</a>; <a href="./references#CD008591-bbs2-0005" title="PjrekE , WilleitM , Praschak-RiederN , KonstantinidisH , SemlitschH , KasperS , et al. Treatment of seasonal affective disorder with duloxetine: an open-label study. Pharmacopsychiatry2008;41(3):100-5. ">Pjrek 2008</a>; <a href="./references#CD008591-bbs2-0006" title="HilgerE , WilleitM , Praschak-RiederN , StastnyJ , NeumeisterA , KasperS . Reboxetine in seasonal affective disorder: an open trial. European Neuropsychopharmacology2001;11:1-5. PjrekE , KonstantinidisA , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine. European Neuropsychopharmacology2009;19 Suppl 3:S404. PjrekE , KonstantinidisH , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis. Journal of Psychiatric Research2009;43:792-7. PjrekE , WinklerD , StastnyJ , Praschak-RiederN , WilleitM , KasperS . Escitalopram in seasonal affective disorder: results of an open trial. Pharmacopsychiatry2007;40(1):20-4. ">Pjrek 2009</a>; <a href="./references#CD008591-bbs2-0008" title="ShenJ , KennedySH , LevitanRD , KayumovL , ShapiroCM . The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. Journal of Psychiatry &amp; Neuroscience2005;30(1):11-6. ">Shen 2005</a>). Nonetheless, the authors did not report how the allocation to the particular SGA was decided. All five studies were open‐label, and no attempt was made to blind participants, personnel, or outcome assessors. The interventions and outcomes were clearly described in all studies, and the evaluation in the published articles was based on the results, except for in two studies (<a href="./references#CD008591-bbs2-0001" title="DilsaverSC , QamarAB , Del MedicoVJ . The efficacy of bupropion in winter depression: results of an open trial. Journal of Clinical Psychiatry1992;53(7):252-5. ">Dilsaver 1992</a>; <a href="./references#CD008591-bbs2-0008" title="ShenJ , KennedySH , LevitanRD , KayumovL , ShapiroCM . The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. Journal of Psychiatry &amp; Neuroscience2005;30(1):11-6. ">Shen 2005</a>): <a href="./references#CD008591-bbs2-0001" title="DilsaverSC , QamarAB , Del MedicoVJ . The efficacy of bupropion in winter depression: results of an open trial. Journal of Clinical Psychiatry1992;53(7):252-5. ">Dilsaver 1992</a> did not specify how adverse events were defined or assessed, and <a href="./references#CD008591-bbs2-0008" title="ShenJ , KennedySH , LevitanRD , KayumovL , ShapiroCM . The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. Journal of Psychiatry &amp; Neuroscience2005;30(1):11-6. ">Shen 2005</a> did not report results on adverse events numerically. All five studies were small (12 to 26 participants), and four suffered high attrition: 23% (<a href="./references#CD008591-bbs2-0005" title="PjrekE , WilleitM , Praschak-RiederN , KonstantinidisH , SemlitschH , KasperS , et al. Treatment of seasonal affective disorder with duloxetine: an open-label study. Pharmacopsychiatry2008;41(3):100-5. ">Pjrek 2008</a>), 27% (<a href="./references#CD008591-bbs2-0006" title="HilgerE , WilleitM , Praschak-RiederN , StastnyJ , NeumeisterA , KasperS . Reboxetine in seasonal affective disorder: an open trial. European Neuropsychopharmacology2001;11:1-5. PjrekE , KonstantinidisA , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine. European Neuropsychopharmacology2009;19 Suppl 3:S404. PjrekE , KonstantinidisH , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis. Journal of Psychiatric Research2009;43:792-7. PjrekE , WinklerD , StastnyJ , Praschak-RiederN , WilleitM , KasperS . Escitalopram in seasonal affective disorder: results of an open trial. Pharmacopsychiatry2007;40(1):20-4. ">Pjrek 2009</a>), 33% (<a href="./references#CD008591-bbs2-0008" title="ShenJ , KennedySH , LevitanRD , KayumovL , ShapiroCM . The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. Journal of Psychiatry &amp; Neuroscience2005;30(1):11-6. ">Shen 2005</a>), and 33% (<a href="./references#CD008591-bbs2-0001" title="DilsaverSC , QamarAB , Del MedicoVJ . The efficacy of bupropion in winter depression: results of an open trial. Journal of Clinical Psychiatry1992;53(7):252-5. ">Dilsaver 1992</a>). Overall, the high attrition and small study size resulted in a judgement of high risk of other bias for these studies. The analysis of the risk of bias of the non‐randomised studies is presented in tabular format in <a href="#CD008591-tbl-0003">Table 1</a>, <a href="#CD008591-tbl-0004">Table 2</a>, <a href="#CD008591-tbl-0005">Table 3</a>, <a href="#CD008591-tbl-0006">Table 4</a>, and <a href="#CD008591-tbl-0007">Table 5</a>. </p> </section> </section> <section id="CD008591-sec-0057"> <h3 class="title" id="CD008591-sec-0057">Effects of interventions</h3> <p>See: <a href="./full#CD008591-tbl-0001"><b>Summary of findings 1</b> Fluoxetine compared with placebo for seasonal affective disorder</a>; <a href="./full#CD008591-tbl-0002"><b>Summary of findings 2</b> Fluoxetine compared with light therapy for seasonal affective disorder</a> </p> <p>In this section we present the efficacy and adverse event results for our two main comparisons: SGAs versus placebo and SGAs versus light therapy. We also present a narrative summary of adverse events data for SGAs. </p> <section id="CD008591-sec-0058"> <h4 class="title">Fluoxetine versus placebo</h4> <section id="CD008591-sec-0059"> <h5 class="title">Primary outcome</h5> <section id="CD008591-sec-0060"> <h6 class="title">1.1 Fifty per cent improvement on the Hamilton Depression Scale (HAM‐D) combined with the eight‐item supplementary scale for seasonal affective disorder (Structured Interview Guide for the Hamilton Depression Rating Scale ‐ Seasonal Affective Disorder Version (SIGH‐SAD)) </h6> <p>One five‐week trial of 68 participants randomised participants to 20 mg/day of fluoxetine or placebo (<a href="./references#CD008591-bbs2-0002" title="LamR , GormanC , MichalonM , SteinerM , LevittA , CorralM , et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. American Journal of Psychiatry1995;152(12):1765-70. ">Lam 1995</a>). The risk ratio for clinical response was 1.62 (95% confidence interval (CI) 0.92 to 2.83) (<a href="./references#CD008591-fig-0006" title="">Analysis 1.1</a>). We rated the certainty of evidence as very low. </p> </section> <section id="CD008591-sec-0061"> <h6 class="title">1.2 Fifty per cent improvement on the HAM‐D</h6> <p>No data available.</p> </section> </section> <section id="CD008591-sec-0062"> <h5 class="title">Secondary outcomes</h5> <section id="CD008591-sec-0063"> <h6 class="title">1.3 Clinical Global Impression – Improvement (CGI‐I) score of 1 or 2 (much improved or very much improved) </h6> <p>No data available.</p> </section> <section id="CD008591-sec-0064"> <h6 class="title">1.4 Improvement of quality of life (QOL) as measured by a validated QOL tool</h6> <p>No data available.</p> </section> <section id="CD008591-sec-0065"> <h6 class="title">1.5 Remission, as defined by the study authors</h6> <p>No data available.</p> </section> <section id="CD008591-sec-0066"> <h6 class="title">1.6 Speed of onset of response</h6> <p>No data available.</p> </section> <section id="CD008591-sec-0067"> <h6 class="title">1.7 Occurrence of adverse events</h6> <p>Overall, 35 of 36 participants in the fluoxetine group suffered an adverse event, compared with 29 out of 32 in the placebo group. This corresponds to a risk ratio of 1.07 (95% CI 0.95 to 1.21) (<a href="./references#CD008591-fig-0007" title="">Analysis 1.2</a>). We rated the certainty of evidence as very low. The authors reported no statistically significant differences between groups for any specific adverse event such as headache, insomnia, and dyspepsia, but did not report the exact number of participants in each arm that experienced these adverse events. Adverse events are presented in <a href="#CD008591-tbl-0008">Table 6</a>. </p> <div class="table" id="CD008591-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Adverse events</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="left" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Lam 2006</b> </p> </th> <th align="left" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Lam 1995</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dilsaver 1992</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Pjrek 2007</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Pjrek 2008</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Pjrek 2009</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Shen 2005</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study design</b> </p> </th> <th align="left" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>RCT</b> </p> </th> <th align="left" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>RCT</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Open‐label observational study</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Open‐label observational study</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Open‐label observational study</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Open‐label observational study</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Open‐label observational study</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>SGA</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fluoxetine</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Light therapy</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fluoxetine</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Placebo</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Bupoprion</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Escitalopram</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Duloxetine</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Reboxetine</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Nefazodone</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants (N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 48</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 48</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 36</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 32</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 15</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 20</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 26</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 15</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 9</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall AEs (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawal due to AEs (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="10" rowspan="1" valign="top"> <p><b>Gastrointestinal</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Abdominal pain (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nausea (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diarrhoea (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Constipation (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Decreased appetite (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increased appetite (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weight loss (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="10" rowspan="1" valign="top"> <p><b>Central nervous system</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anxiety (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nervousness (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Agitation (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dizziness (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tremor (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Irritability (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleepiness (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increased sleep (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Decreased sleep (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleep disturbance (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44.4</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Headache (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Paraesthesia (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="10" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Decreased sex drive (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Male erection problems (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Female delayed orgasm (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="10" rowspan="1" valign="top"> <p><b>Other</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Feeling faint (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Palpitations (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60.0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sweating (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Flushing (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Muscle pain (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weakness/fatigue (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rash (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dry mouth (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypersalivation (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dry eyes (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Urinary retention (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Concentration problems (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dilated pupils (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emotional indifference (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Photosensitivity (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vivid dreams (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychomotor agitation (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Orthostatic dysregulation (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60.0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Accomodative dysfunction (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> </table> <div class="table-footnote"> <p>AE: adverse event; RCT: randomised controlled trial; SGA: second‐generation antidepressant</p> </div> </div> <p>Results for this comparison and the illustrative comparative risks are presented in <a href="./full#CD008591-tbl-0001">summary of findings Table 1</a>. </p> </section> </section> </section> <section id="CD008591-sec-0068"> <h4 class="title">Fluoxetine versus light therapy</h4> <section id="CD008591-sec-0069"> <h5 class="title">Primary outcome</h5> <section id="CD008591-sec-0070"> <h6 class="title">2.1 Fifty per cent improvement on the Hamilton Depression Scale (HAM‐D) combined with the eight‐item supplementary scale for seasonal affective disorder (Structured Interview Guide for the Hamilton Depression Rating Scale ‐ Seasonal Affective Disorder Version (SIGH‐SAD)) </h6> <p>Meta‐analysis of two RCTs (136 participants) showed little to no differences in response and remission between fluoxetine and light therapy. Response was assessed after five, <a href="./references#CD008591-bbs2-0007" title="RuhrmannS , KasperS , HawellekB , MartinezB , HöflichG , NickelsonT , et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychological Medicine1998;28:923-33. RuhrmannS , KasperS , HawellekB , MartinezB , HoflichG , NickelsenT , et al. Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder (SAD) [abstract]. Pharmacopsychiatry [abstracts from the 18th Symposium of AGNP, Nuremberg 1993]1993;26:193. RuhrmannS , KasperS , HawellekB , PetersS , RaoML , HoflichG , et al. Selective serotonin re-uptake inhibitors for treatment of seasonal affective disorder (SAD) [poster abstract]. Clinical Neuropharmacology1992;15(Suppl 1, Pt B):341. ">Ruhrmann 1998</a>, or eight weeks, <a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>, based on a greater than 50% improvement in the 24‐item SIGH‐SAD tool. The pooled risk ratio of response was 0.98 (95% CI 0.77 to 1.24, low‐certainty evidence) (<a href="./references#CD008591-fig-0008" title="">Analysis 2.1</a>; <a href="#CD008591-fig-0004">Figure 4</a>). This corresponds to a response rate of between 66% and 68% for both comparators. Heterogeneity for this result was low (I<sup>2</sup> = 0%). Using a random‐effects model (as sensitivity analysis) resulted in the same pooled effect. </p> <div class="figure" id="CD008591-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: Fluoxetine versus light therapy, outcome: 1.1 Response (&gt; 50% improvement on 24‐item HAM‐D SIGH‐SAD)." data-id="CD008591-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: Fluoxetine versus light therapy, outcome: 1.1 Response (&gt; 50% improvement on 24‐item HAM‐D SIGH‐SAD). </p> </div> </div> </div> </section> <section id="CD008591-sec-0071"> <h6 class="title">2.2 Fifty per cent improvement on the HAM‐D</h6> <p>No data available.</p> </section> </section> <section id="CD008591-sec-0072"> <h5 class="title">Secondary outcomes</h5> <section id="CD008591-sec-0073"> <h6 class="title">2.3 Clinical Global Impression – Improvement (CGI‐I) score of 1 or 2 (much improved or very much improved) </h6> <p>No data available.</p> </section> <section id="CD008591-sec-0074"> <h6 class="title">1.4 Improvement of quality of life (QOL) as measured by a validated QOL tool</h6> <p>Data were available for health‐related quality of life from one trial with 96 participants (<a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>). The authors found little to no difference in improvement in quality of life between the fluoxetine and light therapy groups on two scales: the 20‐Item Short Form Health Survey (SF‐20) (fluoxetine group = mean change from baseline 9.38 (SD 14.39) versus light group = mean change from baseline 7.82 (standard deviation (SD) 15.49) ) the mean difference of mean changes from baseline was 1.56 (95% CI ‐4.42 to 7.54); and the Quality of Life Enjoyment and Satisfaction Questionnaire (Q‐LES‐Q) (fluoxetine = mean change from baseline 21.77 (SD 17.04) versus light therapy = mean change from baseline 20.56 (SD 13.11)), mean difference of mean changes from baseline was 1.21 (‐4.87 to 7.29). We rated the certainty of evidence as low. </p> </section> <section id="CD008591-sec-0075"> <h6 class="title">1.5 Remission, as defined by the study authors</h6> <p>Between 46% and 50% of participants in both study arms achieved remission (<a href="./references#CD008591-bbs2-0007" title="RuhrmannS , KasperS , HawellekB , MartinezB , HöflichG , NickelsonT , et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychological Medicine1998;28:923-33. RuhrmannS , KasperS , HawellekB , MartinezB , HoflichG , NickelsenT , et al. Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder (SAD) [abstract]. Pharmacopsychiatry [abstracts from the 18th Symposium of AGNP, Nuremberg 1993]1993;26:193. RuhrmannS , KasperS , HawellekB , PetersS , RaoML , HoflichG , et al. Selective serotonin re-uptake inhibitors for treatment of seasonal affective disorder (SAD) [poster abstract]. Clinical Neuropharmacology1992;15(Suppl 1, Pt B):341. ">Ruhrmann 1998</a>, <a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>). Heterogeneity for this outcome was high (I<sup>2</sup> = 61%), which may be attributed to greater difference in the rate of remission between the two groups in the smaller trial. Presumably this is a result of a very low number of participants in this trial (N = 40). The pooled risk ratio of remission is 0.91 (95% CI 0.64 to 1.30) (<a href="./references#CD008591-fig-0009" title="">Analysis 2.2</a>; <a href="#CD008591-fig-0005">Figure 5</a>). We performed sensitivity analysis using a random‐effects model. The pooled result was similar: RR 0.81 (95% CI 0.39, 1.71). We rated the certainty of evidence as very low. </p> <div class="figure" id="CD008591-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: Fluoxetine versus light therapy, outcome: 1.2 Remission (response plus end score 8 or less)." data-id="CD008591-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: Fluoxetine versus light therapy, outcome: 1.2 Remission (response plus end score 8 or less). </p> </div> </div> </div> </section> <section id="CD008591-sec-0076"> <h6 class="title">1.6 Speed of onset of response</h6> <p>No data available.</p> </section> <section id="CD008591-sec-0077"> <h6 class="title">1.7 Occurrence of adverse events</h6> <p>Overall, similar numbers of participants in the fluoxetine and light therapy groups experienced an adverse event (75% in for fluoxetine versus 77% for light treatment, risk ratio 0.97, 95% CI 0.78 to 1.22, low‐certainty evidence; <a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>) (<a href="./references#CD008591-fig-0010" title="">Analysis 2.3</a>). The authors reported the number of cases of specific adverse events in each group, with differences between groups for only three adverse events (agitation, sleep disturbance, and palpitations, all worse with fluoxetine compared to placebo) (<a href="./references#CD008591-fig-0011" title="">Analysis 2.4</a>; <a href="./references#CD008591-fig-0012" title="">Analysis 2.5</a>; <a href="./references#CD008591-fig-0013" title="">Analysis 2.6</a>); however, the effect rate for all adverse events was low, and confidence intervals were very wide. Details on the number of adverse events in each group are provided in <a href="#CD008591-tbl-0008">Table 6</a>. </p> <p>Results for this comparison and the illustrative comparative risks are presented in <a href="./full#CD008591-tbl-0002">summary of findings Table 2</a>. </p> </section> </section> </section> <section id="CD008591-sec-0078"> <h4 class="title">3. SGAs versus other SGA</h4> <p>We did not find any eligible study for this comparison.</p> </section> <section id="CD008591-sec-0079"> <h4 class="title">4. SGAs versus psychotherapy</h4> <p>We did not find any eligible study for this comparison.</p> </section> <section id="CD008591-sec-0080"> <h4 class="title">Narrative summary of adverse events: bupropion, fluoxetine, escitalopram, duloxetine, nefazodone, reboxetine </h4> <p>We obtained controlled data on adverse events from two RCTs (<a href="./references#CD008591-bbs2-0002" title="LamR , GormanC , MichalonM , SteinerM , LevittA , CorralM , et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. American Journal of Psychiatry1995;152(12):1765-70. ">Lam 1995</a>; <a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>), and crude rates of specific adverse events from five observational studies (<a href="./references#CD008591-bbs2-0001" title="DilsaverSC , QamarAB , Del MedicoVJ . The efficacy of bupropion in winter depression: results of an open trial. Journal of Clinical Psychiatry1992;53(7):252-5. ">Dilsaver 1992</a>; <a href="./references#CD008591-bbs2-0004" title="PjrekE , KonstantinidisA , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine. European Neuropsychopharmacology2009;19 Suppl 3:S404. PjrekE , WinklerD , StastnyJ , Praschak-RiederN , WilleitM , KasperS . Escitalopram in seasonal affective disorder: results of an open trial. Pharmacopsychiatry2007;40(1):20-4. ">Pjrek 2007</a>; <a href="./references#CD008591-bbs2-0005" title="PjrekE , WilleitM , Praschak-RiederN , KonstantinidisH , SemlitschH , KasperS , et al. Treatment of seasonal affective disorder with duloxetine: an open-label study. Pharmacopsychiatry2008;41(3):100-5. ">Pjrek 2008</a>; <a href="./references#CD008591-bbs2-0006" title="HilgerE , WilleitM , Praschak-RiederN , StastnyJ , NeumeisterA , KasperS . Reboxetine in seasonal affective disorder: an open trial. European Neuropsychopharmacology2001;11:1-5. PjrekE , KonstantinidisA , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine. European Neuropsychopharmacology2009;19 Suppl 3:S404. PjrekE , KonstantinidisH , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis. Journal of Psychiatric Research2009;43:792-7. PjrekE , WinklerD , StastnyJ , Praschak-RiederN , WilleitM , KasperS . Escitalopram in seasonal affective disorder: results of an open trial. Pharmacopsychiatry2007;40(1):20-4. ">Pjrek 2009</a>; <a href="./references#CD008591-bbs2-0008" title="ShenJ , KennedySH , LevitanRD , KayumovL , ShapiroCM . The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. Journal of Psychiatry &amp; Neuroscience2005;30(1):11-6. ">Shen 2005</a>), on fluoxetine (<a href="./references#CD008591-bbs2-0002" title="LamR , GormanC , MichalonM , SteinerM , LevittA , CorralM , et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. American Journal of Psychiatry1995;152(12):1765-70. ">Lam 1995</a>; <a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>), bupropion (<a href="./references#CD008591-bbs2-0001" title="DilsaverSC , QamarAB , Del MedicoVJ . The efficacy of bupropion in winter depression: results of an open trial. Journal of Clinical Psychiatry1992;53(7):252-5. ">Dilsaver 1992</a>), escitalopram (<a href="./references#CD008591-bbs2-0004" title="PjrekE , KonstantinidisA , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine. European Neuropsychopharmacology2009;19 Suppl 3:S404. PjrekE , WinklerD , StastnyJ , Praschak-RiederN , WilleitM , KasperS . Escitalopram in seasonal affective disorder: results of an open trial. Pharmacopsychiatry2007;40(1):20-4. ">Pjrek 2007</a>), duloxetine (<a href="./references#CD008591-bbs2-0005" title="PjrekE , WilleitM , Praschak-RiederN , KonstantinidisH , SemlitschH , KasperS , et al. Treatment of seasonal affective disorder with duloxetine: an open-label study. Pharmacopsychiatry2008;41(3):100-5. ">Pjrek 2008</a>), nefazodone (<a href="./references#CD008591-bbs2-0008" title="ShenJ , KennedySH , LevitanRD , KayumovL , ShapiroCM . The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. Journal of Psychiatry &amp; Neuroscience2005;30(1):11-6. ">Shen 2005</a>), and reboxetine (<a href="./references#CD008591-bbs2-0006" title="HilgerE , WilleitM , Praschak-RiederN , StastnyJ , NeumeisterA , KasperS . Reboxetine in seasonal affective disorder: an open trial. European Neuropsychopharmacology2001;11:1-5. PjrekE , KonstantinidisA , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine. European Neuropsychopharmacology2009;19 Suppl 3:S404. PjrekE , KonstantinidisH , Assem-HilgerE , Praschak-RiederN , WilleitM , KasperS , et al. Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis. Journal of Psychiatric Research2009;43:792-7. PjrekE , WinklerD , StastnyJ , Praschak-RiederN , WilleitM , KasperS . Escitalopram in seasonal affective disorder: results of an open trial. Pharmacopsychiatry2007;40(1):20-4. ">Pjrek 2009</a>). One RCT included for efficacy provided no evidence on adverse events (<a href="./references#CD008591-bbs2-0007" title="RuhrmannS , KasperS , HawellekB , MartinezB , HöflichG , NickelsonT , et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychological Medicine1998;28:923-33. RuhrmannS , KasperS , HawellekB , MartinezB , HoflichG , NickelsenT , et al. Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder (SAD) [abstract]. Pharmacopsychiatry [abstracts from the 18th Symposium of AGNP, Nuremberg 1993]1993;26:193. RuhrmannS , KasperS , HawellekB , PetersS , RaoML , HoflichG , et al. Selective serotonin re-uptake inhibitors for treatment of seasonal affective disorder (SAD) [poster abstract]. Clinical Neuropharmacology1992;15(Suppl 1, Pt B):341. ">Ruhrmann 1998</a>). The SGA arms of these studies involved a total of 169 participants; we obtained data regarding adverse events from 249 participants. Quantitative analysis of the comparative rates of adverse events between SGAs was not possible due to a lack of data, therefore a narrative overview of adverse events with crude rates for all of the included SGAs is presented here. It is important to note that the data presented here on adverse events are not robust, and any interpretation of the data needs to be undertaken with caution. </p> <p>Overall, between 0% and 100% of participants in the SGA groups suffered an adverse event. Between 0% and 25% of participants withdrew from the study because of adverse events. An overview of all adverse events is provided in <a href="#CD008591-tbl-0008">Table 6</a>. The most common adverse events were: nausea (range 10% to 54%); diarrhoea (range 5% to 23%); sleep disturbance (range 8% to 44%); decreased sex drive (range 15% to 20%); dry mouth (range 11% to 86%); and psychomotor agitation (73% (data for reboxetine only)). <a href="./references#CD008591-bbs2-0008" title="ShenJ , KennedySH , LevitanRD , KayumovL , ShapiroCM . The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. Journal of Psychiatry &amp; Neuroscience2005;30(1):11-6. ">Shen 2005</a> reported numerical results on sleep disturbance (insomnia), and reported generally that the most frequent adverse events at week 4 were headache, difficulty concentrating, dry mouth, and increased thirst without providing specific numbers, and that all had disappeared at eight weeks of study duration. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD008591-sec-0081" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD008591-sec-0081"></div> <section id="CD008591-sec-0082"> <h3 class="title" id="CD008591-sec-0082">Summary of main results</h3> <p>We aimed to assess the efficacy and safety of SGAs for the treatment of SAD in adults. In particular, we wanted to find and pool randomised trials of SGAs versus placebo to determine if SGAs are efficacious for SAD and to define the adverse events profile compared with placebo. Furthermore, we hoped to locate head‐to‐head studies of SGAs compared with other SGAs or with light therapy or psychotherapy to determine the comparative efficacy of SGAs. </p> <p>We found evidence on only one SGA, fluoxetine. Based on the results of the single available RCT, it is not clear that fluoxetine is more efficacious than placebo for SAD. The risk ratio (RR) of depression response favours fluoxetine, but the confidence interval includes both a beneficial and no beneficial effect of fluoxetine (RR 1.62, 95% CI 0.92 to 2.83). We assessed the risk of bias for this trial as unclear in most domains, that is random sequence generation, allocation concealment, blinding, and attrition. The certainty of evidence for this effect is very low because the trial has an unclear risk of bias in most domains, and the effect is imprecise. There was an approximately equal occurrence of adverse events in the two groups; however, the reporting of adverse events in this study was poor (only an overall adverse event rate is reported). Future trials should seek to clarify the incidence of specific treatment‐emergent adverse events in participants with SAD receiving fluoxetine versus those receiving placebo. The results of this comparison are presented in <a href="./full#CD008591-tbl-0001">summary of findings Table 1</a>. </p> <p>Similarly, the pooled results from two RCTs of fluoxetine versus light therapy did not demonstrate superior response of either therapy (RR 0.98, 95% CI 0.77 to 1.24). We assessed the certainty of evidence as low, as risk of bias was high in one study, and imprecision was also high because the optimal information size was not achieved. Adverse events data were available from one of the trials, which showed generally similar proportions in both groups. The results of this comparison are presented in <a href="./full#CD008591-tbl-0002">summary of findings Table 2</a>. </p> <p>Overall, adverse events data were sparse, and no comparative analysis of the rates of adverse events between SGAs was possible (data on adverse events are presented in <a href="#CD008591-tbl-0008">Table 6</a>). Overall, 0 to 25% of participants treated with SGAs for SAD withdrew from the study early due to adverse events (across all studies 24 of 201). Because of the lack of evidence for the safety of SGAs when used for SAD, it may be reasonable to assume that SGAs have a similar adverse events profile when used in people with SAD and those suffering from major depressive disorder. One large systematic review of all SGAs for major depressive disorder provides evidence on the incidence of adverse events (<a href="./references#CD008591-bbs2-0023" title="GartlehnerG , MorganLC , ThiedaP , ThalerK , HansenRA , GaynesB , et al. Drug class review: Second generation antidepressants [Drug Effectiveness Review Project (DERP) report]. Oregon, USA: Oregon Health &amp; Science University, October 2008.">Gartlehner 2008</a>). Overall, 61% of participants in 80 trials reported at least one adverse event. The most common adverse events were constipation, diarrhoea, dizziness, insomnia, nausea, sexual adverse events, and somnolence. </p> </section> <section id="CD008591-sec-0083"> <h3 class="title" id="CD008591-sec-0083">Overall completeness and applicability of evidence</h3> <p>All three RCTs and the five non‐randomised studies included adult participants with moderate depression who met the DSM‐III or DSM‐IV criteria for SAD (depression with a seasonal pattern). The trials were conducted in North America (Canada and the USA) and Europe (Germany and Austria). Standard doses and method of administration of fluoxetine were used throughout. The studies varied between five and eight weeks in duration, which is an adequate time frame in which to see effects on response according to the German Depression Guideline (<a href="./references#CD008591-bbs2-0022" title="DGPPN, BÄK, KBV, AWMF, AKDÄ, BPTK, et al. S3-Leitlinie/Nationale Versorgungs-Leitlinie Unipolare Depression - Langfassung [S3-Guideline/National Guideline on unipolar depression - long version]. DGPPN BÄK KBV AWMF AdkÄ BPtK BApK DAGSHG DEGAM DGPM DGPs DGRW für die Leitliniengruppe Unipolare Depression, 2015.">DGPPN 2015</a>). In order to fully elucidate adverse events, a longer time period would probably have been necessary. The primary outcome of this review, response to treatment, was measured in all included RCTs. Overall, the available evidence is too weak to make robust conclusions. Furthermore, no head‐to‐head evidence on the comparative effectiveness of SGAs or a comparison with psychotherapy was available. Lastly, the data were too sparse to conduct any comparative quantitative analyses of adverse events. </p> <section id="CD008591-sec-0084"> <h4 class="title">Certainty of the evidence</h4> <p>For the comparison of fluoxetine with placebo, we graded the certainty of evidence for the outcomes treatment response and adverse events as very low. The certainty of the evidence was limited by the quality of the study because all domains but one were rated as unclear risk of bias). It was also limited by serious imprecision due to the small sample size and broad confidence intervals. No data were reported in the identified trial for our secondary outcomes (for details see <a href="./full#CD008591-tbl-0001">summary of findings Table 1</a>). </p> <p>For the second comparison, we included two RCTs of fluoxetine versus light therapy with a total of 136 participants. We rated the certainty of evidence as low for the outcome treatment response, due to a high risk of bias and imprecision (small sample size) in one study. For remission, we rated the certainty of evidence as very low. We rated down for inconsistency between the two pooled studies, imprecision, and because one study had a high risk of bias. For quality of life, we also assessed the certainty of evidence as very low. We rated down because of imprecision and indirectness and because no relative effect was calculated, so no direct comparison was possible. For adverse events, the certainty of the evidence was low because of very serious imprecision. No data were reported for our other secondary outcomes (for details see <a href="./full#CD008591-tbl-0002">summary of findings Table 2</a>). </p> <p>The non‐randomised studies included for the purpose of evaluating adverse event outcomes suffered high attrition and did not blind participants or outcome assessors. Our confidence in the results presented from these studies was very low because of their observational design, high risk of bias, and small study size (resulting in very serious imprecision). </p> </section> </section> <section id="CD008591-sec-0085"> <h3 class="title" id="CD008591-sec-0085">Potential biases in the review process</h3> <p>We conducted extensive searches. Despite this, publication bias remains a threat for systematic reviews, and we cannot rule out the possibility that we may have missed some trials of SGAs conducted in participants with SAD. </p> <p>We focused on SAD patients in the context of MDD and excluded studies with SAD patients with bipolar disorder. Therefore we also excluded the study by Moscovitch et al. (<a href="./references#CD008591-bbs2-0012" title="BlashkoC . A double-blind, placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder. In: 8th ECNP (European College of Neuropsychopharmacology) Congress; 1995 09 30 - 10 04; Venice, Italy. Venice, Italy: European College of Neuropsychopharmacology, 1995. BlashkoC . Drug treatment of winter depression: How effective is it, and what can it tell us about the biology of SAD? In: Sixth World Congress of Biological Psychiatry; 1997 06 22-27, Nice, France. Nice, France: World Federation of the Societies of Biological Psychiatry, 1997. MoscovitchA , BlashkoC , EaglesJ , DarcoutG , ThompsonC , KasperS , et al. A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder. Psychopharmacology2004;171(4):390-7. ">Moscovitch 2004</a>) although the proportion of SAD patients with bipolar disorder was only 10%.  The results are in agreement with our results for the comparison of SGA vs. placebo. Moscovitch et al. compared sertraline with placebo and also  showed no statistical significant difference in response with 55.9% of participants achieving response in the sertraline group and 50% achieving response under placebo. A future update of this review might consider broadening the inclusion criteria to also include studies with a small proportion of bipolar SAD patients. </p> </section> <section id="CD008591-sec-0086"> <h3 class="title" id="CD008591-sec-0086">Agreements and disagreements with other studies or reviews</h3> <p>The first version of this review (<a href="./references#CD008591-bbs2-0059" title="ThalerK , DelivukM , ChapmanA , GaynesBN , KaminskiA , GartlehnerG . Second-generation antidepressants for seasonal affective disorder. Cochrane Database of Systematic Reviews2011, Issue 12. Art. No: CD008591. [DOI: 10.1002/14651858.CD008591.pub2]">Thaler 2011</a>) came to the same conclusion as this update. A recent Health Technology Assessment also concluded that SGAs and light therapy show similar treatment effects (<a href="./references#CD008591-bbs2-0047" title="Nussbaumer-StreitB , TitscherV , Zechmeister-KossI , StanakM , KallabS , Kaminski-HartenthalerA , et al. Seasonal affective disorder: do non-medical treatments like light therapy and vitamin therapy lead to better results? [Original title of the health techonolgy assessment: Herbst-Winter-Depression Führen nicht medikamentöse Verfahren wie Licht- und Vitamintherapie zu besseren Ergebnissen?]. Cologne, Germany: Institute for Quality and Efficiency in Health Care [Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen], 2020.">Nussbaumer‐Streit 2020</a>).  </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD008591-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/urn:x-wiley:14651858:media:CD008591:CD008591-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD008591-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_t/tCD008591-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008591-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/urn:x-wiley:14651858:media:CD008591:CD008591-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD008591-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_t/tCD008591-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008591-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/urn:x-wiley:14651858:media:CD008591:CD008591-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD008591-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_t/tCD008591-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008591-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/urn:x-wiley:14651858:media:CD008591:CD008591-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: Fluoxetine versus light therapy, outcome: 1.1 Response (&gt; 50% improvement on 24‐item HAM‐D SIGH‐SAD)." data-id="CD008591-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_t/tCD008591-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: Fluoxetine versus light therapy, outcome: 1.1 Response (&gt; 50% improvement on 24‐item HAM‐D SIGH‐SAD). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008591-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/urn:x-wiley:14651858:media:CD008591:CD008591-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: Fluoxetine versus light therapy, outcome: 1.2 Remission (response plus end score 8 or less)." data-id="CD008591-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_t/tCD008591-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: Fluoxetine versus light therapy, outcome: 1.2 Remission (response plus end score 8 or less). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008591-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/urn:x-wiley:14651858:media:CD008591:CD008591-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Fluoxetine versus placebo, Outcome 1: Response (&gt; 50% improvement on 29‐item HAM‐D SIGH‐SAD)" data-id="CD008591-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_t/tCD008591-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Fluoxetine versus placebo, Outcome 1: Response (&gt; 50% improvement on 29‐item HAM‐D SIGH‐SAD) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/references#CD008591-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008591-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/urn:x-wiley:14651858:media:CD008591:CD008591-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Fluoxetine versus placebo, Outcome 2: Harm: overall adverse events" data-id="CD008591-fig-0007" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_t/tCD008591-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Fluoxetine versus placebo, Outcome 2: Harm: overall adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/references#CD008591-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008591-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/urn:x-wiley:14651858:media:CD008591:CD008591-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Fluoxetine versus light therapy, Outcome 1: Response (&gt; 50% improvement on 24‐item HAM‐D SIGH‐SAD)" data-id="CD008591-fig-0008" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_t/tCD008591-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Fluoxetine versus light therapy, Outcome 1: Response (&gt; 50% improvement on 24‐item HAM‐D SIGH‐SAD) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/references#CD008591-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008591-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/urn:x-wiley:14651858:media:CD008591:CD008591-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Fluoxetine versus light therapy, Outcome 2: Remission (response plus end score 8 or less)" data-id="CD008591-fig-0009" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_t/tCD008591-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Fluoxetine versus light therapy, Outcome 2: Remission (response plus end score 8 or less) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/references#CD008591-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008591-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/urn:x-wiley:14651858:media:CD008591:CD008591-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Fluoxetine versus light therapy, Outcome 3: Harm: at least 1 treatment‐emergent adverse event" data-id="CD008591-fig-0010" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_t/tCD008591-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Fluoxetine versus light therapy, Outcome 3: Harm: at least 1 treatment‐emergent adverse event </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/references#CD008591-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008591-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/urn:x-wiley:14651858:media:CD008591:CD008591-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Fluoxetine versus light therapy, Outcome 4: Harm: agitation" data-id="CD008591-fig-0011" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_t/tCD008591-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Fluoxetine versus light therapy, Outcome 4: Harm: agitation</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/references#CD008591-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008591-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/urn:x-wiley:14651858:media:CD008591:CD008591-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Fluoxetine versus light therapy, Outcome 5: Harm: sleep disturbance" data-id="CD008591-fig-0012" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_t/tCD008591-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Fluoxetine versus light therapy, Outcome 5: Harm: sleep disturbance</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/references#CD008591-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008591-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/urn:x-wiley:14651858:media:CD008591:CD008591-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Fluoxetine versus light therapy, Outcome 6: Harm: palpitations" data-id="CD008591-fig-0013" src="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_t/tCD008591-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Fluoxetine versus light therapy, Outcome 6: Harm: palpitations</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/references#CD008591-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/media/CDSR/CD008591/image_n/nCD008591-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD008591-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Fluoxetine compared with placebo for seasonal affective disorder</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Fluoxetine compared with placebo for seasonal affective disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with seasonal affective disorder </p> <p><b>Settings:</b> outpatients </p> <p><b>Intervention:</b> fluoxetine </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fluoxetine</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Response (&gt; 50% improvement on 29‐item HAM‐D SIGH‐SAD)</b> </p> <p>5 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 100</b> </p> <p> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>56 per 100</b><br/>(32 to 97) </p> <p> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.62</b> (0.92 to 2.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68<br/>(1 study, <a href="./references#CD008591-bbs2-0002" title="LamR , GormanC , MichalonM , SteinerM , LevittA , CorralM , et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. American Journal of Psychiatry1995;152(12):1765-70. ">Lam 1995</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical Global Impression – Improvement score</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence identified.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence identified.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Remission</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence identified.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Speed of onset of response</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence identified.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall adverse events</b> </p> <p>5 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>91 per 100</b> </p> <p> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>97 per 100</b><br/>(86 to 110) </p> <p> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.07</b> (0.95 to 1.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68<br/>(1 study, <a href="./references#CD008591-bbs2-0002" title="LamR , GormanC , MichalonM , SteinerM , LevittA , CorralM , et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. American Journal of Psychiatry1995;152(12):1765-70. ">Lam 1995</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is the rate in the placebo group. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the fluoxetine group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>HAM‐D SIGH‐SAD</b> : Structured Interview Guide for the Hamilton Depression Rating Scale ‐ Seasonal Affective Disorder Version; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect </p> <p><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different </p> <p><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect </p> <p><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by one level because the trial has an unclear risk of bias in all but one 'Risk of bias' domains, and two levels for serious imprecision due to the small number of participants in the trial and because the confidence interval includes both benefit and no effect. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Fluoxetine compared with placebo for seasonal affective disorder</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD008591-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Fluoxetine compared with light therapy for seasonal affective disorder</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Fluoxetine compared with light therapy for seasonal affective disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with seasonal affective disorder </p> <p><b>Settings:</b> outpatients </p> <p><b>Intervention:</b> fluoxetine </p> <p><b>Comparison:</b> light therapy </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Light therapy</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fluoxetine</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Response (&gt; 50% improvement on 24‐item HAM‐D SIGH‐SAD)</b> </p> <p>5 to 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>67 per 100</b><br/>(52 to 87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.98</b> (0.77 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>136<br/>(2 studies, <a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>, </p> <p><a href="./references#CD008591-bbs2-0007" title="RuhrmannS , KasperS , HawellekB , MartinezB , HöflichG , NickelsonT , et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychological Medicine1998;28:923-33. RuhrmannS , KasperS , HawellekB , MartinezB , HoflichG , NickelsenT , et al. Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder (SAD) [abstract]. Pharmacopsychiatry [abstracts from the 18th Symposium of AGNP, Nuremberg 1993]1993;26:193. RuhrmannS , KasperS , HawellekB , PetersS , RaoML , HoflichG , et al. Selective serotonin re-uptake inhibitors for treatment of seasonal affective disorder (SAD) [poster abstract]. Clinical Neuropharmacology1992;15(Suppl 1, Pt B):341. ">Ruhrmann 1998</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical Global Impression – Improvement score</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No evidence identified.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life (SF‐20 and Q‐LES‐Q)</b> </p> <p>8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SF‐20: The mean change from baseline was 7.82</p> <p>Q‐LES‐Q:The mean change from baseline was 20.26</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SF‐20: The mean change from baseline was 1.56 higher (4.2 lower to 7.32 higher)</p> <p>Q‐LES‐Q:The mean change from baseline was 1.21 higher (4.87 lower to 7.29 higher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96</p> <p>(1 study, <a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mean difference of change from baseline self calculated by review authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Remission (response plus end score 8 or less)</b> </p> <p>5 to 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>55 per 100</b><br/>(22 to 94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.81</b> (0.39 to 1.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>136<br/>(2 studies, <a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>, </p> <p><a href="./references#CD008591-bbs2-0007" title="RuhrmannS , KasperS , HawellekB , MartinezB , HöflichG , NickelsonT , et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychological Medicine1998;28:923-33. RuhrmannS , KasperS , HawellekB , MartinezB , HoflichG , NickelsenT , et al. Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder (SAD) [abstract]. Pharmacopsychiatry [abstracts from the 18th Symposium of AGNP, Nuremberg 1993]1993;26:193. RuhrmannS , KasperS , HawellekB , PetersS , RaoML , HoflichG , et al. Selective serotonin re-uptake inhibitors for treatment of seasonal affective disorder (SAD) [poster abstract]. Clinical Neuropharmacology1992;15(Suppl 1, Pt B):341. ">Ruhrmann 1998</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to onset of response</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No evidence identified</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events (at least 1 treatment‐emergent adverse event)</b> </p> <p>8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>75 per 100</b><br/>(60 to 94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.97</b> (0.78 to 1.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96</p> <p>(1 study, <a href="./references#CD008591-bbs2-0003" title="CheungA , DewaC , MichalakEE , BrowneG , LevittA , LevitanRD , et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Research and Treatment2012;628434:1-5. EnnsMW , CoxBJ , LevittAJ , LevitanRD , MorehouseR , MichalakEE , et al. Personality and seasonal affective disorder: results from the CAN-SAD study. Journal of Affective Disorders2006;93(1-3):35-42. LamRW , LevittAJ , LevitanRD , EnnsMW , MorehouseR , MichalakEE , et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry2006;163(5):805-12. MichalakEE , MurrayG , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study. Psychological Medicine2007;37(5):727-36. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders2006;90(2-3):227-31. MurrayG , MichalakEE , LevittAJ , LevitanRD , EnnsMW , MorehouseR , et al. Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?Chronobiology International2005;22(5):937-43. ">Lam 2006</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low<sup>4</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is the response rate in the light therapy groups in the 2 included trials. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the fluoxetine group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>HAM‐D SIGH‐SAD</b> : Structured Interview Guide for the Hamilton Depression Rating Scale ‐ Seasonal Affective Disorder Version; <b>NR:</b> not reported; <b>Q‐LES‐Q:</b> Quality of Life Enjoyment and Satisfaction Questionnaire; <b>RR:</b> risk ratio; <b>SF‐20:</b> 20‐Item Short Form Health Survey </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect </p> <p><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different </p> <p><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect </p> <p><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by one level because the risk of bias was high in one study, and one level for imprecision because the optimal information size was not reached (too few participants).<br/><sup>2</sup>The data are from only one trial with a low risk of bias; however, we downgraded by two level for imprecision because the optimal information size was not reached (too few participants) and the confidence interval was broad including both a benefit for fluoxetin and for light therapy.<br/><sup>3</sup>Downgraded by one level for inconsistency, one level because the risk of bias was high in one study, and one level for imprecision because the optimal information size was not reached (too few participants).<br/><sup>4</sup>The data are from only one trial with a low risk of bias; however, we downgraded by one level for imprecision because the optimal information size was not reached (too few participants), and one level for indirectness because the outcome encompasses many adverse effects, allowing no direct conclusions. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Fluoxetine compared with light therapy for seasonal affective disorder</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008591-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">'Risk of bias' table (non‐randomised study), Dilsaver 1992</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Domain</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Authors' judgement</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Support for judgement</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>How did allocation occur? Was there concealment of allocation?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All participants received active therapy with bupropion. No concealment of allocation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blinding? (participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Open‐label</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Follow‐up equal and complete?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33% attrition</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline comparability of groups?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 group</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intention‐to‐treat analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intention‐to‐treat analysis not employed.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly described.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome of interest (adverse events) not clearly specified.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interpretation based on results?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">'Risk of bias' table (non‐randomised study), Dilsaver 1992</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008591-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">'Risk of bias' table (non‐randomised study), Pjrek 2007</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Domain</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Authors' judgement</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Support for judgement</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>How did allocation occur? Was there concealment of allocation?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All participants received active therapy with escitalopram. No concealment of allocation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blinding? (participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Open‐label</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Follow‐up equal and complete?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10% attrition</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline comparability of groups?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 group</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intention‐to‐treat analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intention‐to‐treat analysis employed.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly described.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified, including prospective adverse events recording with Udvalg for Kliniske Undersogelser<br/>(UKU) Side Effect Rating Scale. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interpretation based on results?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">'Risk of bias' table (non‐randomised study), Pjrek 2007</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008591-tbl-0005"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">'Risk of bias' table (non‐randomised study), Pjrek 2008</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Domain</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Authors' judgement</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Support for judgement</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>How did allocation occur? Was there concealment of allocation?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All participants received active therapy with duloxetine. No concealment of allocation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blinding? (participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Open‐label</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Follow‐up equal and complete?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23% attrition</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline comparability of groups?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 group</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intention‐to‐treat analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LOCF analysis employed.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly described.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified, including prospective adverse events recording with Udvalg for Kliniske Undersogelser<br/>(UKU) Side Effect Rating Scale. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interpretation based on results?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No, due to high attrition and use of LOCF approach for missing data</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>LOCF: last observation carried forward</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">'Risk of bias' table (non‐randomised study), Pjrek 2008</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008591-tbl-0006"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">'Risk of bias' table (non‐randomised study), Pjrek 2009</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Domain</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Authors' judgement</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Support for judgement</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>How did allocation occur? Was there concealment of allocation?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All participants received active therapy with reboxetine. No concealment of allocation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blinding? (participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Open‐label</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Follow‐up equal and complete?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27% attrition</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline comparability of groups?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 group</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intention‐to‐treat analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LOCF analysis employed.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly described.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified, including prospective adverse events recording with Udvalg for Kliniske Undersogelser<br/>(UKU) Side Effect Rating Scale. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interpretation based on results?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No, due to high attrition and use of LOCF approach for missing data</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>LOCF: last observation carried forward</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">'Risk of bias' table (non‐randomised study), Pjrek 2009</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008591-tbl-0007"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">'Risk of bias' table (non‐randomised study), Shen 2005</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Domain</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Authors' judgement</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Support for judgement</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>How did allocation occur? Was there concealment of allocation?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All participants received active therapy with nefazodone. No concealment of allocation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blinding? (participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Open‐label</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Follow‐up equal and complete?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33% attrition</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline comparability of groups?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 group</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intention‐to‐treat analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No intention‐to‐treat analysis employed.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention clearly described.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes clearly specified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For adverse events a questionnaire was used (no details about the questionnaire).</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interpretation based on results?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High risk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events are reported vaguely without presentation of absolute numbers.</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">'Risk of bias' table (non‐randomised study), Shen 2005</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008591-tbl-0008"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Adverse events</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="left" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Lam 2006</b> </p> </th> <th align="left" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Lam 1995</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dilsaver 1992</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Pjrek 2007</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Pjrek 2008</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Pjrek 2009</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Shen 2005</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study design</b> </p> </th> <th align="left" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>RCT</b> </p> </th> <th align="left" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>RCT</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Open‐label observational study</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Open‐label observational study</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Open‐label observational study</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Open‐label observational study</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Open‐label observational study</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>SGA</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fluoxetine</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Light therapy</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fluoxetine</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Placebo</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Bupoprion</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Escitalopram</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Duloxetine</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Reboxetine</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Nefazodone</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants (N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 48</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 48</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 36</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 32</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 15</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 20</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 26</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 15</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N = 9</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall AEs (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawal due to AEs (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="10" rowspan="1" valign="top"> <p><b>Gastrointestinal</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Abdominal pain (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nausea (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diarrhoea (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Constipation (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Decreased appetite (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increased appetite (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weight loss (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="10" rowspan="1" valign="top"> <p><b>Central nervous system</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anxiety (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nervousness (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Agitation (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dizziness (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tremor (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Irritability (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleepiness (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increased sleep (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Decreased sleep (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleep disturbance (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44.4</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Headache (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Paraesthesia (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="10" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Decreased sex drive (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Male erection problems (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Female delayed orgasm (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="10" rowspan="1" valign="top"> <p><b>Other</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Feeling faint (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Palpitations (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60.0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sweating (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Flushing (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Muscle pain (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weakness/fatigue (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rash (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dry mouth (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypersalivation (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dry eyes (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Urinary retention (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Concentration problems (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dilated pupils (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Emotional indifference (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Photosensitivity (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vivid dreams (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychomotor agitation (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Orthostatic dysregulation (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60.0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Accomodative dysfunction (%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>AE: adverse event; RCT: randomised controlled trial; SGA: second‐generation antidepressant</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/full#CD008591-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008591-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Fluoxetine versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Response (&gt; 50% improvement on 29‐item HAM‐D SIGH‐SAD) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Harm: overall adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Fluoxetine versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/references#CD008591-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008591-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Fluoxetine versus light therapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Response (&gt; 50% improvement on 24‐item HAM‐D SIGH‐SAD) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.77, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Remission (response plus end score 8 or less) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.64, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Harm: at least 1 treatment‐emergent adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Harm: agitation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Harm: sleep disturbance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Harm: palpitations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Fluoxetine versus light therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008591.pub3/references#CD008591-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD008591.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD008591-note-0009">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD008591-note-0018">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD008591-note-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD008591-note-0016">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD008591-note-0014">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD008591-note-0012">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD008591-note-0013">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD008591-note-0017">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD008591-note-0011">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD008591-note-0008">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD008591-note-0010">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008591\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008591\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008591\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008591\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008591\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008591.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008591.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD008591.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD008591.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008591.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727272574"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008591.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727272578"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008591.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ea80538839377',t:'MTc0MDcyNzI3Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 